PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
2587125-2	1989	SOD activity in PMN was measured with nitroblue tetrazolium reduction assay on PAGE, and the SOD content in PMN was determined with an ELISA using a monoclonal antibody against human copper and zinc-containing SOD.	Nitroblue Tetrazolium	38-59	superoxide dismutase 1	Homo sapiens	0-3
2625004-0	1989	Binding of nitroblue tetrazolium to human serum albumin in a fructosamine test.	Nitroblue Tetrazolium	11-32	albumin	Homo sapiens	42-55
2529540-4	1989	Loss of MYC seems to be associated with granulocytic differentiation because the time course of its loss was similar to that of appearance of nitroblue tetrazolium-positive cells, mature granulocytes, and its loss was not observed on differentiation of HL-60 cells into macrophages induced by phorbol 12-myristate 13-acetate or teleocidin.	Nitroblue Tetrazolium	142-163	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	8-11
2474569-4	1989	Incubation of human monocytes with anti-CD36 MAbs or IRBC resulted in stimulation of the respiratory burst as measured by reduction of nitroblue tetrazolium and generation of chemiluminescence.	Nitroblue Tetrazolium	135-156	CD36 molecule	Homo sapiens	40-44
2722888-1	1989	The interaction between superoxide dismutase (SOD) and peroxide, under anaerobic conditions in the presence of an OH radical scavenger, formate, and an indicator, nitro blue tetrazolium, involves five reactions and an equilibrium: (table; see text) Reaction 3 occurs at a rate that is proportional to both peroxide and enzyme with no kinetic evidence for any intermediate peroxide-enzyme complex.	Nitroblue Tetrazolium	163-185	superoxide dismutase 1	Homo sapiens	24-44
2722888-1	1989	The interaction between superoxide dismutase (SOD) and peroxide, under anaerobic conditions in the presence of an OH radical scavenger, formate, and an indicator, nitro blue tetrazolium, involves five reactions and an equilibrium: (table; see text) Reaction 3 occurs at a rate that is proportional to both peroxide and enzyme with no kinetic evidence for any intermediate peroxide-enzyme complex.	Nitroblue Tetrazolium	163-185	superoxide dismutase 1	Homo sapiens	46-49
2472158-8	1989	When the lower adherence was corrected for, IFN-alpha enhanced NBT reduction.	Nitroblue Tetrazolium	63-66	interferon alpha 1	Homo sapiens	44-53
2497971-3	1989	Assessing suspension cultures containing cells from patients with acute myeloid leukemia (11 patients) or myeloid blast crisis of chronic myeloid leukemia (5 patients), it was found that recombinant human TNF-alpha and IFN-gamma significantly enhanced the number of cells reducing nitroblue tetrazolium, as compared to control cultures containing no cytokine (P less than 0.001 and P less than 0.001, respectively).	Nitroblue Tetrazolium	281-302	tumor necrosis factor	Homo sapiens	205-214
2497971-3	1989	Assessing suspension cultures containing cells from patients with acute myeloid leukemia (11 patients) or myeloid blast crisis of chronic myeloid leukemia (5 patients), it was found that recombinant human TNF-alpha and IFN-gamma significantly enhanced the number of cells reducing nitroblue tetrazolium, as compared to control cultures containing no cytokine (P less than 0.001 and P less than 0.001, respectively).	Nitroblue Tetrazolium	281-302	interferon gamma	Homo sapiens	219-228
2547045-1	1989	When a liver perfusion with nitro blue tetrazolium (NBT) and phorbol myristate acetate (PMA) was performed in carbon tetrachloride (CCl4)-intoxicated rats, formazan deposition was remarkable in macrophages in the necrotic areas of the liver, its intensity varying with the extent of injury.	Nitroblue Tetrazolium	28-50	C-C motif chemokine ligand 4	Rattus norvegicus	132-136
2722807-6	1989	Human DIF-A was found to induce maturation of human and murine leukemic cells into both macrophage-like cells with nitro blue tetrazolium reducing activity and phagocytic cells, but was found to suppress proliferation of these leukemic cells.	Nitroblue Tetrazolium	115-137	LIF interleukin 6 family cytokine	Homo sapiens	6-9
2547324-5	1989	The inclusion of BCS in the NBT assay system was shown to make the accurate measurement of SOD activity in tissues with interferences possible.	Nitroblue Tetrazolium	28-31	superoxide dismutase 1	Homo sapiens	91-94
2547045-3	1989	The formazan content after incubation with NBT and PMA was higher in macrophages isolated from CCl4-intoxicated liver than in those from normal liver, though their PMA-induced chemiluminescence did not differ.	Nitroblue Tetrazolium	43-46	C-C motif chemokine ligand 4	Rattus norvegicus	95-99
2558980-2	1989	NAD[P]H + phenazine + O2 was found to reduce nitroblue tetrazolium, iodonitrotetrazolium, and thiazolyl blue in a manner sensitive to agents that dismutase O2-., viz., SOD and Mn(II).	Nitroblue Tetrazolium	45-66	superoxide dismutase 1	Homo sapiens	168-171
3136768-1	1988	Porcine kidney diamine oxidase, a PQQ-enzyme, can be directly measured by formazan production with putrescine and nitroblue tetrazolium.	Nitroblue Tetrazolium	114-135	amine oxidase copper containing 1	Homo sapiens	15-30
2586142-5	1989	If the leukemia cells were pretreated with a kind of PKC inhibitor such as trifluoperazine, the increase of PKC activity was inhibited, and the rate of nitroblue tetrazolium reduction decreased from 89.9 +/- 7.7% to 62 +/- 25% (n = 6, p less than 0.01) and the mature cells reduced from 63.1 +/- 11.7% to 19.7 +/- 12.2% (p less than 0.01).	Nitroblue Tetrazolium	152-173	proline rich transmembrane protein 2	Homo sapiens	53-56
3278750-6	1988	Subpopulation recruitment by GM-CSF treatment was also demonstrated by the FMLP-elicited NBT test.	Nitroblue Tetrazolium	89-92	colony stimulating factor 2	Homo sapiens	29-35
2843172-9	1988	Myeloperoxidase catalytically inhibited O2- -dependent reduction of Nitro Blue Tetrazolium.	Nitroblue Tetrazolium	68-90	myeloperoxidase	Homo sapiens	0-15
2459585-3	1988	The enhancement of NBT reduction by tyrosine phosphate was blocked by superoxide dismutase (SOD).	Nitroblue Tetrazolium	19-22	superoxide dismutase 1	Homo sapiens	70-90
2459585-3	1988	The enhancement of NBT reduction by tyrosine phosphate was blocked by superoxide dismutase (SOD).	Nitroblue Tetrazolium	19-22	superoxide dismutase 1	Homo sapiens	92-95
3209423-6	1988	This compared to a non-linear reduction of NBT during the initial stages of the reactions (SDH and "nothing dehydrogenase") when using PMS and cyanide.	Nitroblue Tetrazolium	43-46	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	91-94
3278750-6	1988	Subpopulation recruitment by GM-CSF treatment was also demonstrated by the FMLP-elicited NBT test.	Nitroblue Tetrazolium	89-92	formyl peptide receptor 1	Homo sapiens	75-79
3132023-2	1988	We reported a modified procedure for histochemical demonstration of guanase in human tissues involving hydrolytic deamination of the substrate guanine to xanthine via guanase, and then oxidation of xanthine to uric acid, with concomitant reduction of nitrotetrazolium blue (NBT).	Nitroblue Tetrazolium	251-272	guanine deaminase	Homo sapiens	68-75
3349599-1	1988	This assay for superoxide dismutase (SOD, EC 1.15.1.1) activity involves inhibition of nitroblue tetrazolium reduction, with xanthine-xanthine oxidase used as a superoxide generator.	Nitroblue Tetrazolium	87-108	superoxide dismutase 1	Homo sapiens	15-35
3349599-1	1988	This assay for superoxide dismutase (SOD, EC 1.15.1.1) activity involves inhibition of nitroblue tetrazolium reduction, with xanthine-xanthine oxidase used as a superoxide generator.	Nitroblue Tetrazolium	87-108	superoxide dismutase 1	Homo sapiens	37-40
3132023-2	1988	We reported a modified procedure for histochemical demonstration of guanase in human tissues involving hydrolytic deamination of the substrate guanine to xanthine via guanase, and then oxidation of xanthine to uric acid, with concomitant reduction of nitrotetrazolium blue (NBT).	Nitroblue Tetrazolium	274-277	guanine deaminase	Homo sapiens	68-75
2820533-5	1987	In a dose-dependent fashion, TNF enhanced HL-60 cell nonspecific esterase activity, H2O2 production, NBT reduction, and acid phosphatase content.	Nitroblue Tetrazolium	101-104	tumor necrosis factor	Homo sapiens	29-32
2838494-4	1988	A test for fructosamine quantification is based on nitroblue tetrazolium (NBT) reduction, in which O2- is involved, the reduction being inhibited in the presence of superoxide dismutase (SOD).	Nitroblue Tetrazolium	51-72	superoxide dismutase 1	Homo sapiens	165-185
2838494-4	1988	A test for fructosamine quantification is based on nitroblue tetrazolium (NBT) reduction, in which O2- is involved, the reduction being inhibited in the presence of superoxide dismutase (SOD).	Nitroblue Tetrazolium	51-72	superoxide dismutase 1	Homo sapiens	187-190
2838494-4	1988	A test for fructosamine quantification is based on nitroblue tetrazolium (NBT) reduction, in which O2- is involved, the reduction being inhibited in the presence of superoxide dismutase (SOD).	Nitroblue Tetrazolium	74-77	superoxide dismutase 1	Homo sapiens	165-185
2838494-4	1988	A test for fructosamine quantification is based on nitroblue tetrazolium (NBT) reduction, in which O2- is involved, the reduction being inhibited in the presence of superoxide dismutase (SOD).	Nitroblue Tetrazolium	74-77	superoxide dismutase 1	Homo sapiens	187-190
2838494-9	1988	Reduction of NBT by the Amadori compounds formed is inhibited by SOD.	Nitroblue Tetrazolium	13-16	superoxide dismutase 1	Homo sapiens	65-68
2848181-4	1988	Peritoneal exudate macrophages (PEM) of guinea pigs exposed in vitro to various doses of CRP for 72 hr resulted in the development of O2- production dose-dependently, measured by increases in superoxide dismutase-inhibitable nitro blue tetrazolium reduction.	Nitroblue Tetrazolium	225-247	C-reactive protein	Cavia porcellus	89-92
3123808-5	1988	In the responsive patients morphologic changes consistent with monocytic maturation, as well as a strong increase of alpha-naphthyl acetate esterase activity and of nitroblue tetrazolium reducing capability were observed upon culture with rIFN-gamma.	Nitroblue Tetrazolium	165-186	interferon gamma	Rattus norvegicus	239-249
3498485-2	1987	Concomitantly, IL-1 stimulated the prostaglandin E2 synthesis and nitroblue tetrazolium dye-reducing capacity of JOSK-I cells.	Nitroblue Tetrazolium	66-87	interleukin 1 alpha	Homo sapiens	15-19
3607277-2	1987	Normal human eosinophils were found to respond to formyl-methionyl-leucyl-phenylalanine (fMLP) at concentrations greater than 10(-7) mol/L with an increase in the concentration of intracellular free calcium, oxygen consumption, nitroblue tetrazolium reduction, and chemiluminescence.	Nitroblue Tetrazolium	228-249	formyl peptide receptor 1	Homo sapiens	89-93
3663400-1	1987	It has been established that the pyrogallol autoxidation method for the estimation of the activity of superoxide dismutase (SOD) (EC 1.15.1.1) is superior in precision and sensitivity to a superoxide-generating method (NADH/phenazine methosulfate linked to nitroblue tetrazolium reduction).	Nitroblue Tetrazolium	257-278	superoxide dismutase 1	Homo sapiens	102-122
3663400-1	1987	It has been established that the pyrogallol autoxidation method for the estimation of the activity of superoxide dismutase (SOD) (EC 1.15.1.1) is superior in precision and sensitivity to a superoxide-generating method (NADH/phenazine methosulfate linked to nitroblue tetrazolium reduction).	Nitroblue Tetrazolium	257-278	superoxide dismutase 1	Homo sapiens	124-127
3801673-2	1987	Buffy coat granulocytes incubated with as little as 0.5 ng/mL of recombinant TNF (rTNF) showed a dose-related increase in nitroblue tetrazolium dye reduction, in granulocyte polarization, in superoxide anion release, and in visually apparent aggregation.	Nitroblue Tetrazolium	122-143	tumor necrosis factor	Homo sapiens	77-80
3109415-1	1987	Natural or recombinant human tumor necrosis factor (TNF) induced NBT-reducing activity of ML-1 cells in a dose-dependent manner.	Nitroblue Tetrazolium	65-68	tumor necrosis factor	Homo sapiens	29-50
3109415-1	1987	Natural or recombinant human tumor necrosis factor (TNF) induced NBT-reducing activity of ML-1 cells in a dose-dependent manner.	Nitroblue Tetrazolium	65-68	tumor necrosis factor	Homo sapiens	52-55
3109415-2	1987	Interferon-gamma (IFN-gamma) induced NBT-reducing activity only marginally.	Nitroblue Tetrazolium	37-40	interferon gamma	Homo sapiens	0-27
3109415-3	1987	However, when IFN-gamma was combined with TNF, induction of NBT-reducing activity was remarkably increased.	Nitroblue Tetrazolium	60-63	interferon gamma	Homo sapiens	14-23
3109415-3	1987	However, when IFN-gamma was combined with TNF, induction of NBT-reducing activity was remarkably increased.	Nitroblue Tetrazolium	60-63	tumor necrosis factor	Homo sapiens	42-45
3109415-5	1987	Treatment with both TNF and IFN-gamma synergistically enhanced morphological changes, growth inhibition and activity of Fc receptors, and NBT reduction in ML-1 cells, but not phagocytic activity.	Nitroblue Tetrazolium	138-141	tumor necrosis factor	Homo sapiens	20-23
3109415-5	1987	Treatment with both TNF and IFN-gamma synergistically enhanced morphological changes, growth inhibition and activity of Fc receptors, and NBT reduction in ML-1 cells, but not phagocytic activity.	Nitroblue Tetrazolium	138-141	interferon gamma	Homo sapiens	28-37
3099861-7	1987	Based on units of antiviral activity, rIFN-gamma is tenfold more active than rIFN-alpha D in inducing EA rosettes and 40-fold more active in inducing nitroblue tetrazolium reduction and immunophagocytosis.	Nitroblue Tetrazolium	150-171	interferon gamma	Rattus norvegicus	38-48
3606573-4	1987	The induction of P47 by retinoic acid preceded cessation of cell proliferation and development of the capacity to reduce Nitro Blue Tetrazolium, indicating that its expression is an early event in the myeloid differentiation of HL-60 cells.	Nitroblue Tetrazolium	121-143	pleckstrin	Homo sapiens	17-20
2441083-4	1987	These results suggest that cytochrome c is directly reduced by the cuprous ion released from bleomycin-Cu (II) in a reducing reaction with cysteine and nitroblue tetrazolium chloride is reduced by the superoxide anion formed in the reaction of the cuprous ion with oxygen.	Nitroblue Tetrazolium	152-182	cytochrome c, somatic	Homo sapiens	27-39
3102606-4	1987	Appearance of the monocytic phenotype was manifested within 24 hr of IFN-gamma exposure by: increased nitroblue tetrazolium reduction; increased cell surface expression of the HLA-DR, Mo1, and MY4 antigens; and induction of transcripts for the second component of complement (C2) and tumor necrosis factor.	Nitroblue Tetrazolium	102-123	interferon gamma	Homo sapiens	69-78
3098042-0	1986	Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages.	Nitroblue Tetrazolium	84-105	interferon gamma	Mus musculus	48-64
2946400-3	1986	The number of cells with the ability to reduce nitroblue tetrazolium increased in the TPA-treated cell lines HL-60, ML-3, THP-1, and U-937, whereas the cell lines KG-1 and KLM-2 remained nitroblue tetrazolium negative.	Nitroblue Tetrazolium	47-68	GLI family zinc finger 2	Homo sapiens	122-127
3027925-2	1986	The appearance of superoxide anion radical in cerebral extracellular space during VIP application was examined by measuring the rate of superoxide dismutase (SOD)-inhibitable reduction of nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	188-209	vasoactive intestinal peptide	Felis catus	82-85
3027925-2	1986	The appearance of superoxide anion radical in cerebral extracellular space during VIP application was examined by measuring the rate of superoxide dismutase (SOD)-inhibitable reduction of nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	211-214	vasoactive intestinal peptide	Felis catus	82-85
3027925-3	1986	Although VIP (1 and 10 micrograms/ml) caused substantial reduction of NBT, the rate of the SOD-inhibitable portion was not significantly different from zero.	Nitroblue Tetrazolium	70-73	vasoactive intestinal peptide	Felis catus	9-12
2836672-6	1987	Zymosan-induced NBT reduction increased slightly during monocyte to macrophage differentiation and was further enhanced by continuous presence of IFN gamma.	Nitroblue Tetrazolium	16-19	interferon gamma	Homo sapiens	146-155
3025874-5	1987	and reduce nitroblue tetrazolium dye on appropriate stimulation; they respond chemotactically to erythrocytes destroyed by laser microirradiation or to the specific chemoattractants fMet-Leu-Phe (10 nM) and C5a (zymosan-activated serum); and they ingest and kill staphylococci.	Nitroblue Tetrazolium	11-32	complement C5a receptor 1	Homo sapiens	207-210
3096330-2	1986	Both IFN-gamma and rTNF-alpha induced the appearance of the monocytic phenotype in a dose- and time-dependent manner as assessed by morphology, reduction of nitroblue tetrazolium and the induction of alpha-naphthyl butyrate esterase.	Nitroblue Tetrazolium	157-178	interferon gamma	Homo sapiens	5-14
3096330-2	1986	Both IFN-gamma and rTNF-alpha induced the appearance of the monocytic phenotype in a dose- and time-dependent manner as assessed by morphology, reduction of nitroblue tetrazolium and the induction of alpha-naphthyl butyrate esterase.	Nitroblue Tetrazolium	157-178	tumor necrosis factor	Rattus norvegicus	19-29
3093627-2	1986	After 5 d of culture in the presence of rTNF and LT, a significant proportion of the myeloid cell lines express monocyte differentiation antigens and ANAE activity, and become able to reduce nitroblue tetrazolium (NBT) and mediate low levels of ADCC against tumor target cells.	Nitroblue Tetrazolium	191-212	tumor necrosis factor	Rattus norvegicus	40-51
3093627-2	1986	After 5 d of culture in the presence of rTNF and LT, a significant proportion of the myeloid cell lines express monocyte differentiation antigens and ANAE activity, and become able to reduce nitroblue tetrazolium (NBT) and mediate low levels of ADCC against tumor target cells.	Nitroblue Tetrazolium	214-217	tumor necrosis factor	Rattus norvegicus	40-51
3017475-8	1986	The percentage of depolarizing PMNs in response to FMLP was significantly correlated with the percentage of NBT-positive cells from both purified PMNs and from whole blood (r = .849, P less than .0005, r = .857, P less than .05, respectively), and with the amount of superoxide produced, expressed as a percentage of that amount produced by cytochalasin B (cyto-B)-pretreated cells (r = .565, P less than .01).	Nitroblue Tetrazolium	108-111	formyl peptide receptor 1	Homo sapiens	51-55
2411582-1	1985	The monoblastlike leukemia cell line, U-937, is induced to differentiate into monocytelike cells by incubation with 200-500 U/ml of recombinant human immune interferon (IFN-gamma) judging from capacity to reduce nitroblue tetrazolium.	Nitroblue Tetrazolium	212-233	interferon gamma	Homo sapiens	150-178
3955232-8	1986	Stimulated nitroblue tetrazolium (NBT) tests performed on PMNs from mothers of CGD patients indicated that cytochrome b deficiency was associated with X-linked inheritance, except in one case in which probable autosomal recessive inheritance was demonstrated.	Nitroblue Tetrazolium	11-32	mitochondrially encoded cytochrome b	Homo sapiens	107-119
2417997-5	1985	Next the D-glyceraldehyde-3-phosphate is oxidized by exogenous and endogenous glyceraldehyde-3-phosphate dehydrogenase and the electrons are transported concomitantly via NAD+, phenazine methosulphate and menadione to nitro-BT.	Nitroblue Tetrazolium	218-226	glyceraldehyde-3-phosphate dehydrogenase	Homo sapiens	78-118
4052375-5	1985	ETF-QO catalyzes the transfer of electrons from electron-transfer flavoprotein (ETF) to nitro blue tetrazolium, with a sluggish reaction turnover number of about 10-30 min-1.	Nitroblue Tetrazolium	88-110	ETF dehydrogenase	Sus scrofa	0-6
4030398-2	1985	The tetrazolium salt tetranitro blue tetrazolium is recommended for the localization of MAO activity, rather than nitro blue tetrazolium or BPST [2-(2-benzothiazolyl)-3-(4-phthalhydrazidyl)-5-styryl-tetrazolium] .	Nitroblue Tetrazolium	26-48	monoamine oxidase A	Rattus norvegicus	88-91
2990646-4	1985	The cell lysis by the superoxide-generating xanthine oxidase system was not significantly increased by SOD, but was significantly decreased by nitroblue tetrazolium and completely abolished by catalase.	Nitroblue Tetrazolium	143-164	xanthine dehydrogenase	Mus musculus	44-60
3886800-12	1985	The results of experiments with scavengers of oxygen reduction intermediates and of nitroblue tetrazolium reduction tests indicated that H2O2, O2- and 1O2 were involved in the killing of AMA by LF-treated MPM.	Nitroblue Tetrazolium	84-105	heme oxygenase 2	Homo sapiens	137-154
2991135-0	1985	NBT dye reduction test & myeloperoxidase activity of neutrophils in pregnant & non-pregnant women.	Nitroblue Tetrazolium	0-3	myeloperoxidase	Homo sapiens	29-44
3922297-5	1985	Bovine liver catalase enhanced the rate of nitroblue tetrazolium reduction and decreased the maximal velocity of the reaction proportionately to catalase concentration.	Nitroblue Tetrazolium	43-64	catalase	Bos taurus	13-21
6607753-5	1984	DIF induced maturation of HL-60 into phagocytizing nitro blue tetrazolium reducing cells with the morphological characteristics of myelomonocytic or monocyte-like cells.	Nitroblue Tetrazolium	51-73	tumor necrosis factor	Homo sapiens	0-3
2981163-1	1985	In this new method for determining serum guanase activity by use of the Hitachi 736-40 automated analyzer, serum is incubated with a mixture of xanthine oxidase, superoxide dismutase, and catalase; a reagent containing KCN, guanine, nitrotetrazolium blue, and Triton X-100 is added; and the increase in absorbance at 570 and 660 nm is measured for 2.4 min.	Nitroblue Tetrazolium	233-254	guanine deaminase	Homo sapiens	41-48
6327830-5	1984	NBT reduction by visible light could be slightly inhibited by SOD, but a 12% decrease of NBT reduction by UV radiation could be shown with the addition of SOD.	Nitroblue Tetrazolium	0-3	superoxide dismutase 1	Homo sapiens	62-65
6327830-5	1984	NBT reduction by visible light could be slightly inhibited by SOD, but a 12% decrease of NBT reduction by UV radiation could be shown with the addition of SOD.	Nitroblue Tetrazolium	89-92	superoxide dismutase 1	Homo sapiens	155-158
6723060-0	1984	Isolation of human fibrinogen using nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	36-57	fibrinogen beta chain	Homo sapiens	19-29
6723060-0	1984	Isolation of human fibrinogen using nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	59-62	fibrinogen beta chain	Homo sapiens	19-29
6495349-5	1984	Microspectrophotometric measurements of matched controls and NBT/acetone preincubated sections show that the preincubation step may slightly decrease lactate dehydrogenase (LDH) and glucose-6-phosphate dehydrogenase (G6PDH) activities.	Nitroblue Tetrazolium	61-64	glucose-6-phosphate dehydrogenase	Homo sapiens	182-215
6495349-5	1984	Microspectrophotometric measurements of matched controls and NBT/acetone preincubated sections show that the preincubation step may slightly decrease lactate dehydrogenase (LDH) and glucose-6-phosphate dehydrogenase (G6PDH) activities.	Nitroblue Tetrazolium	61-64	glucose-6-phosphate dehydrogenase	Homo sapiens	217-222
6607753-6	1984	An activity, co-chromatographing with DIF, acts synergistically with retinoic acid to induce maturation not only of HL-60, but also of the monoblast-like cell line U-937 (measured as percentage of cells reducing NBT).	Nitroblue Tetrazolium	212-215	tumor necrosis factor	Homo sapiens	38-41
6362847-5	1983	Nitroblue tetrazolium (NBT) reduction by resting granulocytes was slightly, although not significantly, increased by preincubation with IFN for 30 min, but their NBT reduction during phagocytosis of E. coli was significantly increased.	Nitroblue Tetrazolium	0-21	interferon alpha 1	Homo sapiens	136-139
6196020-2	1983	Monoamine-oxidase (MAO) activity was detected in rat pineal gland with dopamine, 5-hydroxytryptamine (5-HT), norepinephrine and tryptamine as substrates, and nitroblue tetrazolium salt as electron acceptor.	Nitroblue Tetrazolium	158-184	monoamine oxidase A	Rattus norvegicus	0-17
6196020-2	1983	Monoamine-oxidase (MAO) activity was detected in rat pineal gland with dopamine, 5-hydroxytryptamine (5-HT), norepinephrine and tryptamine as substrates, and nitroblue tetrazolium salt as electron acceptor.	Nitroblue Tetrazolium	158-184	monoamine oxidase A	Rattus norvegicus	19-22
6365781-4	1984	During prolonged treatment with interferon alpha, 1 week to 1 year, granulocytes activated with bacteria exhibited a reduced Nitro Blue Tetrazolium activity in most patients.	Nitroblue Tetrazolium	125-147	interferon alpha 1	Homo sapiens	32-51
6229496-8	1984	The phagocytic activity of granulocytes was not altered during IFN therapy, whereas the capacity of these cells to reduce nitroblue tetrazolium (NBT) increased after the first injection of IFN.	Nitroblue Tetrazolium	122-143	interferon alpha 1	Homo sapiens	189-192
6229496-8	1984	The phagocytic activity of granulocytes was not altered during IFN therapy, whereas the capacity of these cells to reduce nitroblue tetrazolium (NBT) increased after the first injection of IFN.	Nitroblue Tetrazolium	145-148	interferon alpha 1	Homo sapiens	189-192
6324308-3	1984	When cytochrome c and NBT are simultaneously present the reduction of each is about the same as when either cytochrome c or NBT is present.	Nitroblue Tetrazolium	22-25	cytochrome c, somatic	Homo sapiens	108-120
6324308-3	1984	When cytochrome c and NBT are simultaneously present the reduction of each is about the same as when either cytochrome c or NBT is present.	Nitroblue Tetrazolium	124-127	cytochrome c, somatic	Homo sapiens	5-17
6886073-2	1983	The method involves staining for newly synthesized GABA-T by the previously established nitro blue tetrazolium technique in animals killed 8-48 hours after administration of gabaculine, an irreversible inhibitor of GABA-T.	Nitroblue Tetrazolium	88-110	4-aminobutyrate aminotransferase	Rattus norvegicus	51-57
6301892-2	1983	delta 5-3 beta-Hydroxysteroid dehydrogenase (delta 5-3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activities were detected by Dickmann and Dey"s reaction medium consisting of 1.8 mg substrate (pregnenolone or 17 beta-estradiol [E2]), 4 mg nicotinamide-adenine dinucleotide, 2 mg nitro-blue tetrazolium, 10 ml 0.1 M phosphate buffer.	Nitroblue Tetrazolium	301-323	hydroxysteroid 17-beta dehydrogenase 13	Homo sapiens	69-105
6301892-2	1983	delta 5-3 beta-Hydroxysteroid dehydrogenase (delta 5-3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activities were detected by Dickmann and Dey"s reaction medium consisting of 1.8 mg substrate (pregnenolone or 17 beta-estradiol [E2]), 4 mg nicotinamide-adenine dinucleotide, 2 mg nitro-blue tetrazolium, 10 ml 0.1 M phosphate buffer.	Nitroblue Tetrazolium	301-323	hydroxysteroid 17-beta dehydrogenase 1	Homo sapiens	107-118
6362847-5	1983	Nitroblue tetrazolium (NBT) reduction by resting granulocytes was slightly, although not significantly, increased by preincubation with IFN for 30 min, but their NBT reduction during phagocytosis of E. coli was significantly increased.	Nitroblue Tetrazolium	23-26	interferon alpha 1	Homo sapiens	136-139
6184578-5	1982	Succinate dehydrogenase and glucose-6-phosphate dehydrogenase were localized with the nitroblue tetrazolium staining reaction.	Nitroblue Tetrazolium	86-107	glucose-6-phosphate dehydrogenase	Homo sapiens	28-61
6291507-6	1982	gamma-Butyrobetaine hydroxylase was inhibited by a number of low-molecular-weight compounds, such as tetranitromethane, Nitro Blue Tetrazolium, adrenaline and Tiron, which may act as scavengers of superoxide anion.	Nitroblue Tetrazolium	120-142	gamma-butyrobetaine hydroxylase 1	Homo sapiens	0-31
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	62-83	nuclear receptor subfamily 5 group A member 1	Homo sapiens	5-8
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	62-83	FA complementation group B	Homo sapiens	9-12
7097752-0	1982	Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes.	Nitroblue Tetrazolium	53-56	fibronectin 1	Homo sapiens	0-11
7097752-0	1982	Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes.	Nitroblue Tetrazolium	58-79	fibronectin 1	Homo sapiens	0-11
7097752-1	1982	Neutrophilic granulocytes preincubated in vitro with human plasma fibronectin (0-1.25 mg/ml) for 30 minutes showed increased spontaneous and chemotactic migration, increased uptake of fluorescein labelled yeast particles as well as higher NBT-reduction both with and without E. coli stimulation.	Nitroblue Tetrazolium	239-242	fibronectin 1	Homo sapiens	66-77
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	62-83	nuclear receptor subfamily 5 group A member 1	Homo sapiens	17-20
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	85-88	nuclear receptor subfamily 5 group A member 1	Homo sapiens	5-8
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	85-88	FA complementation group B	Homo sapiens	9-12
7047381-7	1982	Both ELP-Fab and ELP-Fc increase the spontaneous reduction of nitroblue-tetrazolium (NBT) in granulocytes dose-dependent in a homologous as well as in an autologous system.	Nitroblue Tetrazolium	85-88	nuclear receptor subfamily 5 group A member 1	Homo sapiens	17-20
6284006-4	1982	Ceruloplasmin, at concentrations present in normal plasma, inhibited reduction of both cytochrome c and nitroblue tetrazolium (NBT) mediated by the aerobic action of xanthine oxidase on hypoxanthine (a superoxide-generating system).	Nitroblue Tetrazolium	104-125	ceruloplasmin	Homo sapiens	0-13
6284006-4	1982	Ceruloplasmin, at concentrations present in normal plasma, inhibited reduction of both cytochrome c and nitroblue tetrazolium (NBT) mediated by the aerobic action of xanthine oxidase on hypoxanthine (a superoxide-generating system).	Nitroblue Tetrazolium	127-130	ceruloplasmin	Homo sapiens	0-13
6284006-6	1982	Furthermore, in an experimental system in which contact between ceruloplasmin and indicator was prevented by a relatively impermeable lipid membrane barrier, ceruloplasmin inhibited reduction of NBT trapped within liposomes exposed to xanthine oxidase and hypoxanthine.	Nitroblue Tetrazolium	195-198	ceruloplasmin	Homo sapiens	158-171
6284006-6	1982	Furthermore, in an experimental system in which contact between ceruloplasmin and indicator was prevented by a relatively impermeable lipid membrane barrier, ceruloplasmin inhibited reduction of NBT trapped within liposomes exposed to xanthine oxidase and hypoxanthine.	Nitroblue Tetrazolium	195-198	ceruloplasmin	Homo sapiens	64-77
6284006-7	1982	Ceruloplasmin also inhibited reduction of cytochrome c and NBT mediated by the aerobic action of xanthine oxidase on acetaldehyde (another superoxide-generating system) and mimicked the activity of purified human erythrocyte SOD by inhibiting photoreduction of NBT and by accelerating aerobic photooxidation of dianisidine.	Nitroblue Tetrazolium	59-62	ceruloplasmin	Homo sapiens	0-13
6284006-7	1982	Ceruloplasmin also inhibited reduction of cytochrome c and NBT mediated by the aerobic action of xanthine oxidase on acetaldehyde (another superoxide-generating system) and mimicked the activity of purified human erythrocyte SOD by inhibiting photoreduction of NBT and by accelerating aerobic photooxidation of dianisidine.	Nitroblue Tetrazolium	261-264	ceruloplasmin	Homo sapiens	0-13
6895053-3	1981	The hydrogen in the NADH generated is transferred by diaphorase (EC 1.6.4.3) to nitrotetrazolium blue to yield diformazan 540 nm).	Nitroblue Tetrazolium	80-101	dihydrolipoamide dehydrogenase	Homo sapiens	53-63
6975849-2	1981	Mononuclear blood cells, when stimulated with various mitogens, produced DIF, which induced differentiation of HL-60 into phagocytizing nitro blue tetrazolium reducing cells with the morphologic characteristic of granulopoietic or myelomonocytic cells.	Nitroblue Tetrazolium	136-158	tumor necrosis factor	Homo sapiens	73-76
422251-7	1979	These rather poor results are not surprising if one considers that NBT is only taken up by granulocytes as macrocomplex containing heparin or fibrinogen.	Nitroblue Tetrazolium	67-70	fibrinogen beta chain	Homo sapiens	142-152
6160210-3	1980	When the NBT stain was combined with the Karnovsky acetylcholinesterase (AChE) procedure the blue-coloured nerve terminal processes were vividly outlined by the brown copper ferrocyanide-AChE reaction product.	Nitroblue Tetrazolium	9-12	acetylcholinesterase (Cartwright blood group)	Homo sapiens	73-77
6160210-3	1980	When the NBT stain was combined with the Karnovsky acetylcholinesterase (AChE) procedure the blue-coloured nerve terminal processes were vividly outlined by the brown copper ferrocyanide-AChE reaction product.	Nitroblue Tetrazolium	9-12	acetylcholinesterase (Cartwright blood group)	Homo sapiens	187-191
6160210-9	1980	The powerful experimental advantage of the NBT-AChE stain for neuromuscular junctions resulted from the sharp colour contrast which made possible accurate determinations of the relationship between the presynaptic nerve terminal arborization and the postsynaptic junctional AChE activity.	Nitroblue Tetrazolium	43-46	acetylcholinesterase (Cartwright blood group)	Homo sapiens	47-51
6160210-9	1980	The powerful experimental advantage of the NBT-AChE stain for neuromuscular junctions resulted from the sharp colour contrast which made possible accurate determinations of the relationship between the presynaptic nerve terminal arborization and the postsynaptic junctional AChE activity.	Nitroblue Tetrazolium	43-46	acetylcholinesterase (Cartwright blood group)	Homo sapiens	274-278
6160211-2	1980	Presynaptic nerve terminals and postsynaptic acetylcholinesterase (AChE) activity simultaneously demonstrated at these developing junctions using the NBT-AChE method.	Nitroblue Tetrazolium	150-153	acetylcholinesterase (Cartwright blood group)	Homo sapiens	67-71
6160211-2	1980	Presynaptic nerve terminals and postsynaptic acetylcholinesterase (AChE) activity simultaneously demonstrated at these developing junctions using the NBT-AChE method.	Nitroblue Tetrazolium	150-153	acetylcholinesterase (Cartwright blood group)	Homo sapiens	154-158
7448746-0	1980	The effect of VP 16-213 on NBT reduction in the normal polymorphonuclear neutrophil.	Nitroblue Tetrazolium	27-30	host cell factor C1	Homo sapiens	14-19
7448746-1	1980	VP 16-213, an antineoplastic, semisynthetic podophyllotoxin derivative, inhibits NBT reduction in the polymorphonuclear neutrophil (PMN).	Nitroblue Tetrazolium	81-84	host cell factor C1	Homo sapiens	0-5
7448746-5	1980	VP 16-213 may alter normal respiratory function in the PMN as reflected by inhibition of NBT reduction.	Nitroblue Tetrazolium	89-92	host cell factor C1	Homo sapiens	0-5
226386-1	1979	The higher superoxide dismutase (SOD) levels found in human blood cells when Nitro Blue Tetrazolium (NBT) rather than Cytochrome C was used as the colorimetric detector of superoxide (O-2) was investigated.	Nitroblue Tetrazolium	101-104	immunoglobulin kappa variable 1D-39	Homo sapiens	184-187
396798-3	1979	Togheter NBT and vitamin E blockedaggregation by epinephrine, collagen, and thrombin, but permitted a small first wave stimulated by ADP.	Nitroblue Tetrazolium	9-12	coagulation factor II, thrombin	Homo sapiens	76-84
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	145-166	cellular communication network factor 6	Homo sapiens	45-48
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	145-166	cellular communication network factor 6	Homo sapiens	100-103
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	145-166	cellular communication network factor 6	Homo sapiens	100-103
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	168-171	cellular communication network factor 6	Homo sapiens	45-48
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	168-171	cellular communication network factor 6	Homo sapiens	100-103
475666-1	1979	Leucocytes from purified protein derivative (PPD) skin test positive individuals, after exposure to PPD in vitro, show a significant increase in nitroblue tetrazolium (NBT) dye reduction when compared to leucocytes from PPD negative donors.	Nitroblue Tetrazolium	168-171	cellular communication network factor 6	Homo sapiens	100-103
486607-4	1979	In measuring SOD activity, the serum factor has a great effect, and serum contains a substance that inhibits NBT reduction.	Nitroblue Tetrazolium	109-112	superoxide dismutase 1	Homo sapiens	13-16
916943-10	1977	In comparison between the NBT value and the simultaneously examined ALP it was found that ALP is a more sensitive parameter but that an increased ALP is not indicative of an active stage.	Nitroblue Tetrazolium	26-29	ATHS	Homo sapiens	90-93
916943-10	1977	In comparison between the NBT value and the simultaneously examined ALP it was found that ALP is a more sensitive parameter but that an increased ALP is not indicative of an active stage.	Nitroblue Tetrazolium	26-29	ATHS	Homo sapiens	90-93
879276-6	1977	Together NBT and vitamin E blocked aggregation by epinephrine, collagen, and thrombin, but permitted a small first wave stimulated by ADP.	Nitroblue Tetrazolium	9-12	coagulation factor II, thrombin	Homo sapiens	77-85
1254941-4	1976	Antigenic luteinizing hormone was subsequently localized with hydrogen peroxide-3,3"-diaminobenzidine as substrate for peroxidase, and growth hormone was localized with a glucose-phenazine methosulfate-nitroblue tetrazolium mixture as a substrate for glucose oxidase.	Nitroblue Tetrazolium	202-223	gonadotropin releasing hormone receptor	Rattus norvegicus	135-149
181277-2	1976	G6PD was localized in the cells of cortical stroma and hilus using a histochemical technique for the reduction of the tetrazolium salt, Nitro-Blue tetrazolium.	Nitroblue Tetrazolium	136-158	glucose-6-phosphate dehydrogenase	Homo sapiens	0-4
184979-1	1976	The rate of nitrobluetetrazolium reduction by extracts from rodent and human kidney tissue has been measured in the presence and absence of exogeneous superoxide dismutase and catalase.	Nitroblue Tetrazolium	12-32	catalase	Homo sapiens	176-184
1155373-6	1975	Increased NBT reductions by PMN"s was found when leukocytes were incubated with heparin, CSA, and CSB, but these compounds had no effect on the HMPS activity of PMN"s unless NBT was added.	Nitroblue Tetrazolium	10-13	chorionic somatomammotropin hormone 2	Homo sapiens	98-101
1248624-0	1976	Inhibition of nitroblue tetrazolium reduction by cuprein (superoxide dismutase), Cu(tyr)2 and Cu(lys)2.	Nitroblue Tetrazolium	14-35	aminoadipate-semialdehyde dehydrogenase	Homo sapiens	94-102
5539768-0	1971	Nitroblue tetrazolium dye test as an aid in the differential diagnosis of febrile disorders.	Nitroblue Tetrazolium	0-21	activation induced cytidine deaminase	Homo sapiens	37-40
4133405-0	1973	[NBT test, a diagnostic aid in differentiation of pathogenetically different leukocytes and febrile diseases].	Nitroblue Tetrazolium	1-4	activation induced cytidine deaminase	Homo sapiens	24-27
13974734-2	1963	Succinic dehydrogenase (SDH) was localized in the mitochondria of Sarcoma 37 ascites tumor cells by the use of tetranitro-BT (TNBT) and nitro-BT (NBT) in smear preparations.	Nitroblue Tetrazolium	116-124	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	0-22
4295240-3	1968	LDH activity was maximal at the end of the exponential growth period and was measured spectrophotometrically by reduction of p-nitro-blue tetrazolium, with phenazine methosulfate as a coupling agent.	Nitroblue Tetrazolium	125-149	AT695_RS04475	Staphylococcus aureus	0-3
13974734-2	1963	Succinic dehydrogenase (SDH) was localized in the mitochondria of Sarcoma 37 ascites tumor cells by the use of tetranitro-BT (TNBT) and nitro-BT (NBT) in smear preparations.	Nitroblue Tetrazolium	116-124	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	24-27
13974734-2	1963	Succinic dehydrogenase (SDH) was localized in the mitochondria of Sarcoma 37 ascites tumor cells by the use of tetranitro-BT (TNBT) and nitro-BT (NBT) in smear preparations.	Nitroblue Tetrazolium	127-130	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	0-22
13974734-2	1963	Succinic dehydrogenase (SDH) was localized in the mitochondria of Sarcoma 37 ascites tumor cells by the use of tetranitro-BT (TNBT) and nitro-BT (NBT) in smear preparations.	Nitroblue Tetrazolium	127-130	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	24-27
13563553-1	1958	A histochemical method is described for the localization of triphosphopyridine nucleotide diaphorase using a recently synthesized tetrazolium salt (Nitro-BT).	Nitroblue Tetrazolium	148-156	dihydrolipoamide dehydrogenase	Homo sapiens	90-100
33273578-2	2020	It is thought that the catalytic activity of NOS promotes NADPH-dependent reduction of nitro-blue tetrazolium (NBT) to diformazan.	Nitroblue Tetrazolium	87-109	2,4-dienoyl-CoA reductase 1	Homo sapiens	58-63
32935604-5	2021	Our work revealed that the NBT/PMS assay with some modifications can be used to measure the activity of LDH-B and other dehydrogenases in a high-throughput screening format at the early stages of drug discovery.	Nitroblue Tetrazolium	27-30	lactate dehydrogenase B	Homo sapiens	104-109
33273578-2	2020	It is thought that the catalytic activity of NOS promotes NADPH-dependent reduction of nitro-blue tetrazolium (NBT) to diformazan.	Nitroblue Tetrazolium	111-114	2,4-dienoyl-CoA reductase 1	Homo sapiens	58-63
33273578-6	2020	Our results suggest that NADPH diaphorase in aldehyde-fixed tissues is not enzymatic but is due to the presence of NO-containing factors (free SNOs or nitrosated proteins such as NOS), which promote NADPH-dependent reduction of NBT to diformazan.	Nitroblue Tetrazolium	228-231	2,4-dienoyl-CoA reductase 1	Homo sapiens	25-30
31442385-3	2019	Using the interaction of recombinant hCD40 ligand with HEK-Blue sensor cells expressing the CD40 receptor as example, we show that such an assay can be developed based on BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium chloride) as substrate.	Nitroblue Tetrazolium	176-179	CD40 molecule	Homo sapiens	37-42
32850864-10	2020	The proportions of NBT stained area in the matured oocytes and cumulus cells was found significantly lesser in the control as compared to the IL-7 (1 and 5 ng/ml) treated groups.	Nitroblue Tetrazolium	19-22	interleukin 7	Homo sapiens	142-146
32083866-8	2020	Diosmin reduced LPS-induced total ROS production (DCFDA assay) and superoxide anion production (NBT assay and NBT-positive cells).	Nitroblue Tetrazolium	96-99	toll-like receptor 4	Mus musculus	16-19
32083866-8	2020	Diosmin reduced LPS-induced total ROS production (DCFDA assay) and superoxide anion production (NBT assay and NBT-positive cells).	Nitroblue Tetrazolium	110-113	toll-like receptor 4	Mus musculus	16-19
32850864-13	2020	The NBT staining patterns of the oocytes and cumulus cells following the combined treatment with IL-7 (5 ng/ml) and Tempol (10 and 25 mM) were comparable with that of the control.	Nitroblue Tetrazolium	4-7	interleukin 7	Homo sapiens	97-101
32227083-7	2020	NBT staining and pharmacological experiments indicate that ILA induces superoxide formation of the wild type and of an SA-deficient (NahG sid2) line.	Nitroblue Tetrazolium	0-3	ILITYHIA	Arabidopsis thaliana	59-62
32271339-5	2020	These results indicate that NBT-xCT:Sm3+ piezo-luminescent ceramics show great potential applications in white LEDs, as well as novel optical-electronic multifunctional devices.	Nitroblue Tetrazolium	28-31	solute carrier family 7 member 11	Homo sapiens	32-35
31442385-3	2019	Using the interaction of recombinant hCD40 ligand with HEK-Blue sensor cells expressing the CD40 receptor as example, we show that such an assay can be developed based on BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium chloride) as substrate.	Nitroblue Tetrazolium	176-179	CD40 molecule	Homo sapiens	38-42
30606139-11	2019	CONCLUSIONS: These results suggest that the Oct4 gene may regulate NBT pathogenic differentiation pathways, and should thus be considered as a target for knockdown when developing novel therapies for high-risk NBT patients.	Nitroblue Tetrazolium	67-70	POU class 5 homeobox 1	Homo sapiens	44-48
30431398-8	2019	No differences in heart rate, blood glucose and blood lactate responses were apparent, but overall RPE was higher in NBT compared with BT (17.8 +- 0.9 vs 16.7 +- 0.7 au, p < .05).	Nitroblue Tetrazolium	117-120	ribulose-5-phosphate-3-epimerase	Homo sapiens	99-102
29702544-3	2018	The CGD patients were diagnosed according to clinical features and biochemical tests, including nitroblue tetrazolium and dihydrorhodamine-1, 2, 3 tests, performed on patients and their mothers.	Nitroblue Tetrazolium	96-117	cytochrome b-245 beta chain	Homo sapiens	4-7
30289902-8	2018	In deletion PML-RARA-transduced cells, the CD11b expression levels and NBT reducing ability were significantly decreased compared with control cells and the formation of PML nuclear bodies was rarely observed after RA treatment.	Nitroblue Tetrazolium	71-74	retinoic acid receptor alpha	Homo sapiens	16-20
30289902-8	2018	In deletion PML-RARA-transduced cells, the CD11b expression levels and NBT reducing ability were significantly decreased compared with control cells and the formation of PML nuclear bodies was rarely observed after RA treatment.	Nitroblue Tetrazolium	71-74	PML nuclear body scaffold	Homo sapiens	12-15
29886170-3	2018	The purified superoxide dismutase was optimally active at pH 9.0 and displayed stability over a broad pH range of 7.0-10.0 and was stable up to 70  C. SOD was localized in polyacrylamide gel by activity staining, based on the reduction of nitroblue tetrazolium (NBT) by superoxide ion.	Nitroblue Tetrazolium	239-260	superoxide dismutase	Anoxybacillus gonensis	13-33
29886170-3	2018	The purified superoxide dismutase was optimally active at pH 9.0 and displayed stability over a broad pH range of 7.0-10.0 and was stable up to 70  C. SOD was localized in polyacrylamide gel by activity staining, based on the reduction of nitroblue tetrazolium (NBT) by superoxide ion.	Nitroblue Tetrazolium	262-265	superoxide dismutase	Anoxybacillus gonensis	13-33
29888123-12	2018	We found that PRF in combination with NBT increased beta-EP levels and decreased plasma IL-6 and SP, thereby alleviating pain and hyperalgesia in PHN patients.	Nitroblue Tetrazolium	38-41	proopiomelanocortin	Homo sapiens	52-59
29888123-12	2018	We found that PRF in combination with NBT increased beta-EP levels and decreased plasma IL-6 and SP, thereby alleviating pain and hyperalgesia in PHN patients.	Nitroblue Tetrazolium	38-41	interleukin 6	Homo sapiens	88-99
29445224-7	2018	NBT induced cell cycle arrest in the G0/G1 phase by decreasing the expression of cyclin D1.	Nitroblue Tetrazolium	0-3	cyclin D1	Homo sapiens	81-90
29445224-10	2018	The experiments inferred that the combination of NBT and CQ significantly promoted MCF-7 cell mitochondria to divide and Cyt C to be released from mitochondria to the cytoplasm, resulting in an increased apoptosis rate.	Nitroblue Tetrazolium	49-52	cytochrome c, somatic	Homo sapiens	121-126
29087184-6	2017	The superoxide dismutase (SOD) activities of the Cu2+/Cu2+ and Cu2+/Zn2+ complexes of L1 and L2 have been evaluated using nitro blue tetrazolium assays at pH 7.4.	Nitroblue Tetrazolium	122-144	superoxide dismutase 1	Homo sapiens	26-29
29443080-3	2018	It works by soaking the acrylamide or agarose DNA gel in a solution of 1x (equivalent to 2.0 microM) SYBR Green I (SG I) and 0.20 mM nitro blue tetrazolium that produces a purple precipitate of formazan when exposed to sunlight or specifically blue light.	Nitroblue Tetrazolium	133-155	semenogelin 1	Homo sapiens	115-119
29594441-5	2017	After exposure to the sample, a substrate for ALP (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium) was dropped on the test strip.	Nitroblue Tetrazolium	88-110	alkaline phosphatase, placental	Homo sapiens	46-49
29087184-6	2017	The superoxide dismutase (SOD) activities of the Cu2+/Cu2+ and Cu2+/Zn2+ complexes of L1 and L2 have been evaluated using nitro blue tetrazolium assays at pH 7.4.	Nitroblue Tetrazolium	122-144	L1 cell adhesion molecule	Homo sapiens	86-95
28984335-4	2017	The SOD activity was determined by a xanthine-xanthine oxidase-nitro blue tetrazolium assay and the IC50 values were determined to be 1.53 and 2.09 muM, respectively.	Nitroblue Tetrazolium	63-85	superoxide dismutase 1	Homo sapiens	4-7
28471113-8	2017	The activating effect and chemotactic activity of HMGN2 on neutrophils were determined using a nitroblue tetrazolium (NBT) reduction assay and Transwell chamber cell migration assay, respectively.	Nitroblue Tetrazolium	95-116	high mobility group nucleosomal binding domain 2	Homo sapiens	50-55
28471113-8	2017	The activating effect and chemotactic activity of HMGN2 on neutrophils were determined using a nitroblue tetrazolium (NBT) reduction assay and Transwell chamber cell migration assay, respectively.	Nitroblue Tetrazolium	118-121	high mobility group nucleosomal binding domain 2	Homo sapiens	50-55
26628755-9	2015	RESULTS: Significantly impaired phagocytic function as indicated by lower phagocytic, lytic indices and decreased NBT reduction of neutrophils was seen in COPD subjects compared to normal healthy controls (P < .001).	Nitroblue Tetrazolium	114-117	COPD	Homo sapiens	155-159
27836260-2	2017	Here we develop two chromogenic methods for the detection of glucan phosphatase activity in situ after non denaturing poliacrylamide gel electrophoresis; one method uses pNPP and the second one applies BCIP/NBT.	Nitroblue Tetrazolium	207-210	EPM2A glucan phosphatase, laforin	Homo sapiens	61-79
26394634-11	2016	We recommend the X-gal/nitroblue tetrazolium staining mixture as the first choice for the detection of beta-galactosidase activity on histological sections.	Nitroblue Tetrazolium	23-44	galactosidase, beta 1	Mus musculus	103-121
26232605-7	2015	RESULTS: Increased mRNA expression of VEGF-A, IGF-I, and IGF-IR was significantly higher in TNBC (65.1%, 65.1%, and 72.1%) than non-TNBC (28.1%, 33.96% and 28.3%) and NBT (0.00%) (P<0.001).	Nitroblue Tetrazolium	167-170	vascular endothelial growth factor A	Homo sapiens	38-44
26232605-7	2015	RESULTS: Increased mRNA expression of VEGF-A, IGF-I, and IGF-IR was significantly higher in TNBC (65.1%, 65.1%, and 72.1%) than non-TNBC (28.1%, 33.96% and 28.3%) and NBT (0.00%) (P<0.001).	Nitroblue Tetrazolium	167-170	insulin like growth factor 1 receptor	Homo sapiens	57-63
26348407-4	2015	Under physiological conditions, AQP1-/- mice develop normally; however, in the setting of MI, they exhibit cardioprotective properties, as shown by reduced cardiac infarct size determined via NBT staining, improved cardiac function determined via left ventricular catheter measurements, decreased AQP1-dependent myocardial edema determined via water content assays, and decreased apoptosis determined via TUNEL analysis.	Nitroblue Tetrazolium	192-195	aquaporin 1	Mus musculus	32-36
28155600-7	2017	In addition, suppression in cytosolic superoxide-dismutase (Cu-Zn isoform/SOD1; NBT reduction-test) and an insufficient protection through catalase activity culminate free radical-related damages.	Nitroblue Tetrazolium	80-83	superoxide dismutase 1	Rattus norvegicus	74-78
27173532-2	2016	Superoxide radicals (O2(*-)) and their protonated form (hydroperoxyl radicals, HO2(*)) were detected by the reduction of nitroblue tetrazolium into formazan, and hydroxyl radicals (OH(*)) were detected by the hydroxylation of terephthalate.	Nitroblue Tetrazolium	121-142	heme oxygenase 2	Homo sapiens	79-82
27588133-7	2016	Nitroblue tetrazolium (NBT) reduction assays showed decreased NBT reduction activity in the CRT overexpression group and increased NBT reduction in the CRT siRNA group.	Nitroblue Tetrazolium	0-21	calreticulin	Homo sapiens	92-95
27588133-7	2016	Nitroblue tetrazolium (NBT) reduction assays showed decreased NBT reduction activity in the CRT overexpression group and increased NBT reduction in the CRT siRNA group.	Nitroblue Tetrazolium	0-21	calreticulin	Homo sapiens	152-155
27588133-7	2016	Nitroblue tetrazolium (NBT) reduction assays showed decreased NBT reduction activity in the CRT overexpression group and increased NBT reduction in the CRT siRNA group.	Nitroblue Tetrazolium	62-65	calreticulin	Homo sapiens	92-95
27588133-7	2016	Nitroblue tetrazolium (NBT) reduction assays showed decreased NBT reduction activity in the CRT overexpression group and increased NBT reduction in the CRT siRNA group.	Nitroblue Tetrazolium	62-65	calreticulin	Homo sapiens	92-95
27618921-6	2016	RESULTS: Phagocytosis rate was reduced in antigen treated monocytes whereas nitroblue tetrazolium (NBT) reduction was more in apical membrane antigen-1 (AMA-1) and merozoite surface protein-7 (MSP7) treated than in untreated and von Willebrand factor A domain-related protein (WARP) treated monocytes.	Nitroblue Tetrazolium	76-97	von Willebrand factor A domain containing 1	Homo sapiens	229-275
27618921-6	2016	RESULTS: Phagocytosis rate was reduced in antigen treated monocytes whereas nitroblue tetrazolium (NBT) reduction was more in apical membrane antigen-1 (AMA-1) and merozoite surface protein-7 (MSP7) treated than in untreated and von Willebrand factor A domain-related protein (WARP) treated monocytes.	Nitroblue Tetrazolium	76-97	von Willebrand factor A domain containing 1	Homo sapiens	277-281
27618921-6	2016	RESULTS: Phagocytosis rate was reduced in antigen treated monocytes whereas nitroblue tetrazolium (NBT) reduction was more in apical membrane antigen-1 (AMA-1) and merozoite surface protein-7 (MSP7) treated than in untreated and von Willebrand factor A domain-related protein (WARP) treated monocytes.	Nitroblue Tetrazolium	99-102	von Willebrand factor A domain containing 1	Homo sapiens	229-275
27618921-6	2016	RESULTS: Phagocytosis rate was reduced in antigen treated monocytes whereas nitroblue tetrazolium (NBT) reduction was more in apical membrane antigen-1 (AMA-1) and merozoite surface protein-7 (MSP7) treated than in untreated and von Willebrand factor A domain-related protein (WARP) treated monocytes.	Nitroblue Tetrazolium	99-102	von Willebrand factor A domain containing 1	Homo sapiens	277-281
26896642-5	2016	PDI"s inhibitors bacitracin and nitroblue tetrazolium reduced the percent of infected cells and small amounts of recTgPDI proteins interfered with the invasion step.	Nitroblue Tetrazolium	32-53	protein disulfide isomerase family A member 2	Homo sapiens	0-3
26407339-6	2016	Our results show that FOE reports were strongly correlated with arithmetic errors and numerical properties of the NBT, suggesting that the FOE accurately represents the error.	Nitroblue Tetrazolium	114-117	WAPL cohesin release factor	Homo sapiens	22-25
26407339-6	2016	Our results show that FOE reports were strongly correlated with arithmetic errors and numerical properties of the NBT, suggesting that the FOE accurately represents the error.	Nitroblue Tetrazolium	114-117	WAPL cohesin release factor	Homo sapiens	139-142
22969967-7	2012	The results of the NBT reduction test and CD11b antigen detection by FCM indicated that IFN-gamma induces the differentiation of NB4 and NB4-R1 cells to some extent.	Nitroblue Tetrazolium	19-22	interferon gamma	Homo sapiens	88-97
26207760-6	2015	Myoadenylate deaminase (MAD) activity was determined using p-nitro blue tetrazolium staining in muscle cryostat sections.	Nitroblue Tetrazolium	59-83	adenosine monophosphate deaminase 3	Homo sapiens	0-22
26207760-6	2015	Myoadenylate deaminase (MAD) activity was determined using p-nitro blue tetrazolium staining in muscle cryostat sections.	Nitroblue Tetrazolium	59-83	adenosine monophosphate deaminase 3	Homo sapiens	24-27
24357020-7	2014	Treatment with an inhibitor of ERK (PD98059) blocked the nitrotetrazolium blue chloride (NBT) reducing activity and CD11b expression in the N. chinensis-treated HL-60 cells, whereas treatment with an inhibitor of p38 MAPK (SB203580) had no significant effect on NBT reducing activity and CD11b expression.	Nitroblue Tetrazolium	57-87	mitogen-activated protein kinase 1	Homo sapiens	31-34
24357020-7	2014	Treatment with an inhibitor of ERK (PD98059) blocked the nitrotetrazolium blue chloride (NBT) reducing activity and CD11b expression in the N. chinensis-treated HL-60 cells, whereas treatment with an inhibitor of p38 MAPK (SB203580) had no significant effect on NBT reducing activity and CD11b expression.	Nitroblue Tetrazolium	89-92	mitogen-activated protein kinase 1	Homo sapiens	31-34
24357020-7	2014	Treatment with an inhibitor of ERK (PD98059) blocked the nitrotetrazolium blue chloride (NBT) reducing activity and CD11b expression in the N. chinensis-treated HL-60 cells, whereas treatment with an inhibitor of p38 MAPK (SB203580) had no significant effect on NBT reducing activity and CD11b expression.	Nitroblue Tetrazolium	262-265	mitogen-activated protein kinase 1	Homo sapiens	31-34
24288134-10	2014	Redox reactions induced by DA/Cu2+ were observed in multimer regions of alpha-synuclein oligomers through NBT assay.	Nitroblue Tetrazolium	106-109	synuclein alpha	Homo sapiens	72-87
22750339-5	2012	Synthesized complexes have been tested for their SOD mimic activity using NBT/NADH/PMS system.	Nitroblue Tetrazolium	74-77	superoxide dismutase 1	Homo sapiens	49-52
25737734-10	2015	Treatment with 4ME led to significant induction of NBT-reducing activity of PMA stimulated THP-1 cells and upregulation expression of differentiation-associated surface antigen CD11b.	Nitroblue Tetrazolium	51-54	GLI family zinc finger 2	Homo sapiens	91-96
24563327-10	2014	Further investigation showed that cytoplasm TARBP2 expression in non-TNBC was higher than that of their adjacent normal breast tissues (NBT), and TNBC was the highest of the three groups.	Nitroblue Tetrazolium	136-139	TARBP2 subunit of RISC loading complex	Homo sapiens	44-50
24563327-11	2014	The positive expression of cytoplasm TARBP2 in stage III breast cancer, stage I-II breast cancer, and NBT decreased gradually.	Nitroblue Tetrazolium	102-105	TARBP2 subunit of RISC loading complex	Homo sapiens	37-43
24175985-2	2014	METHODS: Glycation of nail proteins was assessed using a modified photometric nitroblue tetrazolium-based assay, which provides information about average glucose values of the last 6-9 months.	Nitroblue Tetrazolium	78-99	CD244 molecule	Homo sapiens	22-26
23395717-9	2013	Inhibition of ERK activation using PD98059 significantly decreased NBT+HL60 cells induced by XC treatment.	Nitroblue Tetrazolium	67-70	mitogen-activated protein kinase 1	Homo sapiens	14-17
23888688-9	2013	HL-60 cells became more mature in morphology after transfected to HDAC1 siRNA at a concentration of 30-60 nmol x L(-1) for 24 h. NBT reduction ability of HDAC1 siRNA with 30 nmol x L(-1) was 0.31 +/- 0.09, compared with negative control (0.20 +/- 0.02) (t = -3.1, P < 0.01), and with 60 nmol x L(-1) was 0.25 +/- 0.02 in comparison with negative control (0.21 +/- 0.04) (t = -2.12, P < 0.05).	Nitroblue Tetrazolium	129-132	histone deacetylase 1	Homo sapiens	66-71
23888688-9	2013	HL-60 cells became more mature in morphology after transfected to HDAC1 siRNA at a concentration of 30-60 nmol x L(-1) for 24 h. NBT reduction ability of HDAC1 siRNA with 30 nmol x L(-1) was 0.31 +/- 0.09, compared with negative control (0.20 +/- 0.02) (t = -3.1, P < 0.01), and with 60 nmol x L(-1) was 0.25 +/- 0.02 in comparison with negative control (0.21 +/- 0.04) (t = -2.12, P < 0.05).	Nitroblue Tetrazolium	129-132	histone deacetylase 1	Homo sapiens	154-159
23456281-4	2013	The generation of superoxides during the oxidation of phenylhydrazine by tyrosinase was monitored by nitroblue tetrazolium (NBT) assay.	Nitroblue Tetrazolium	101-122	tyrosinase	Homo sapiens	73-83
23456281-4	2013	The generation of superoxides during the oxidation of phenylhydrazine by tyrosinase was monitored by nitroblue tetrazolium (NBT) assay.	Nitroblue Tetrazolium	124-127	tyrosinase	Homo sapiens	73-83
23490067-5	2013	Furthermore, activation of extracellular-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) by TPA+AA was identified in HL-60 cells, and the ERK inhibitor, PD98059, but not the JNK inhibitor, SP600125, inhibited TPA+AA-induced NBT-positive cells.	Nitroblue Tetrazolium	233-236	mitogen-activated protein kinase 1	Homo sapiens	27-57
23490067-5	2013	Furthermore, activation of extracellular-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) by TPA+AA was identified in HL-60 cells, and the ERK inhibitor, PD98059, but not the JNK inhibitor, SP600125, inhibited TPA+AA-induced NBT-positive cells.	Nitroblue Tetrazolium	233-236	mitogen-activated protein kinase 1	Homo sapiens	59-62
23490067-5	2013	Furthermore, activation of extracellular-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) by TPA+AA was identified in HL-60 cells, and the ERK inhibitor, PD98059, but not the JNK inhibitor, SP600125, inhibited TPA+AA-induced NBT-positive cells.	Nitroblue Tetrazolium	233-236	mitogen-activated protein kinase 8	Homo sapiens	68-91
23490067-5	2013	Furthermore, activation of extracellular-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) by TPA+AA was identified in HL-60 cells, and the ERK inhibitor, PD98059, but not the JNK inhibitor, SP600125, inhibited TPA+AA-induced NBT-positive cells.	Nitroblue Tetrazolium	233-236	mitogen-activated protein kinase 8	Homo sapiens	93-96
22947512-5	2012	Pharmacological approach using mammalian NOS inhibitors, NBT (300 muM) and l-NAME (5 mM), showed significant inhibition (100% and 67% respectively) supporting that the BjNOSla operates via the oxidative pathway.	Nitroblue Tetrazolium	57-60	latexin	Homo sapiens	66-69
22676437-10	2012	CONCLUSIONS: ALP expression detected using BCIP/NBT substrate applied to previously stained cells is useful in differentiating canine OSA from other mesenchymal neoplasms.	Nitroblue Tetrazolium	48-51	alkaline phosphatase, biomineralization associated	Canis lupus familiaris	13-16
22437533-5	2012	Using nitroblue tetrazolium and hydrogen peroxide assays, we showed that sugar ligand-bound conglutinin stimulated the production of superoxide and H2O2 in granulocytes whereas the non-sugar-bound form of conglutinin inhibited these processes.	Nitroblue Tetrazolium	6-27	conglutinin	Bos taurus	92-103
22143245-15	2011	Those cells with dysfunctional COX will therefore not be saturated by the DAB product, allowing for the visualization of SDH activity by reduction of nitroblue tetrazolium (NBT), an electron acceptor, to a blue formazan end product (9,24).	Nitroblue Tetrazolium	150-171	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	121-124
22101193-5	2012	In the present study, we developed and validated an in situ PREP intracellular activity assay in primary rat cortical neurons, using nitroblue tetrazolium chloride salt (NBT) and a PREP specific substrate (S)-benzyl 2-(2-(4-hydroxynaphthalen-l-ylcarbanoyl)pyrrolidin-l-yl)-2-oxoethylcarbamate (UAMC-00682).	Nitroblue Tetrazolium	170-173	prolyl endopeptidase	Rattus norvegicus	60-64
22085718-3	2011	Upon gene silencing of PCGF2 with lentiviral short hairpin RNA, granulocytic differentiation was induced as assessed by differentiation marker gene expression, nitroblue tetrazolium staining, Wright-Giemsa staining, and cell cycle analysis.	Nitroblue Tetrazolium	160-181	polycomb group ring finger 2	Homo sapiens	23-28
22143245-15	2011	Those cells with dysfunctional COX will therefore not be saturated by the DAB product, allowing for the visualization of SDH activity by reduction of nitroblue tetrazolium (NBT), an electron acceptor, to a blue formazan end product (9,24).	Nitroblue Tetrazolium	173-176	succinate dehydrogenase complex iron sulfur subunit B	Homo sapiens	121-124
20583870-2	2011	The superoxide dismutase (SOD) like activity of the complexes were measured using an NBT/NADH/PMS system, these were expressed in terms of the concentration of complex which termianates the formation of formazan by 50% (IC50 value) and found to range from 0.781 to 1.354 muM.	Nitroblue Tetrazolium	85-88	superoxide dismutase 1	Homo sapiens	4-24
20583870-2	2011	The superoxide dismutase (SOD) like activity of the complexes were measured using an NBT/NADH/PMS system, these were expressed in terms of the concentration of complex which termianates the formation of formazan by 50% (IC50 value) and found to range from 0.781 to 1.354 muM.	Nitroblue Tetrazolium	85-88	superoxide dismutase 1	Homo sapiens	26-29
21086135-7	2010	In addition, in cells induced to differentiate by ATRA or VD3, Nitroblue-tetrazolium (NBT) reduction and esterase activity, were blocked either by LY294002, a PI3K inhibitor, or by BIM, a PKC inhibitor, without affecting cell surface markers such as CD11b or CD14.	Nitroblue Tetrazolium	63-84	protein kinase C alpha	Homo sapiens	188-191
21086135-7	2010	In addition, in cells induced to differentiate by ATRA or VD3, Nitroblue-tetrazolium (NBT) reduction and esterase activity, were blocked either by LY294002, a PI3K inhibitor, or by BIM, a PKC inhibitor, without affecting cell surface markers such as CD11b or CD14.	Nitroblue Tetrazolium	86-89	protein kinase C alpha	Homo sapiens	188-191
21086135-7	2010	In addition, in cells induced to differentiate by ATRA or VD3, Nitroblue-tetrazolium (NBT) reduction and esterase activity, were blocked either by LY294002, a PI3K inhibitor, or by BIM, a PKC inhibitor, without affecting cell surface markers such as CD11b or CD14.	Nitroblue Tetrazolium	86-89	integrin subunit alpha M	Homo sapiens	250-255
21086135-7	2010	In addition, in cells induced to differentiate by ATRA or VD3, Nitroblue-tetrazolium (NBT) reduction and esterase activity, were blocked either by LY294002, a PI3K inhibitor, or by BIM, a PKC inhibitor, without affecting cell surface markers such as CD11b or CD14.	Nitroblue Tetrazolium	86-89	CD14 molecule	Homo sapiens	259-263
21086135-8	2010	Intriguingly, the silencing of Rictor by its siRNA also suppressed the reducing ability of NBT following VD3-induced cell differentiation.	Nitroblue Tetrazolium	91-94	RPTOR independent companion of MTOR complex 2	Homo sapiens	31-37
19907057-9	2010	The nitro blue tetrazolium reduction assay shows that INH is activated by the reaction of LPO-H(2)O(2) with INH.	Nitroblue Tetrazolium	4-26	lactoperoxidase	Bos taurus	90-93
20878073-4	2010	Immunohistochemical analysis in 172 cases of breast tissues showed that the positive rate of CacyBP protein expression in normal breast tissues (NBT) (89.3%) was higher than that in invasive ductal carcinoma (IDC) (56.1%) (P<0.05).	Nitroblue Tetrazolium	145-148	calcyclin binding protein	Homo sapiens	93-99
20889731-0	2010	The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors.	Nitroblue Tetrazolium	26-29	AKT serine/threonine kinase 1	Homo sapiens	51-54
20889731-5	2010	These findings also suggested that the depleting effect of NBT-272 on MYC protein expression occurred via indirect mechanisms, rather than selective inhibition.	Nitroblue Tetrazolium	59-62	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	70-73
20400306-2	2010	The SOD-like activity of parent ligands and complexes were determined by the inhibition of nitroblue tetrazolium (NBT) reduction method, using xanthine/xanthine oxidase as the superoxide radical generator.	Nitroblue Tetrazolium	91-112	superoxide dismutase 1	Homo sapiens	4-7
20400306-2	2010	The SOD-like activity of parent ligands and complexes were determined by the inhibition of nitroblue tetrazolium (NBT) reduction method, using xanthine/xanthine oxidase as the superoxide radical generator.	Nitroblue Tetrazolium	114-117	superoxide dismutase 1	Homo sapiens	4-7
20137124-5	2010	The alteration of NB4R2 cell differentiation with the interference of pkm2 gene was also validated by nitroblue tetrazolium (NBT) reduction test.	Nitroblue Tetrazolium	102-123	pyruvate kinase M1/2	Homo sapiens	70-74
20137124-5	2010	The alteration of NB4R2 cell differentiation with the interference of pkm2 gene was also validated by nitroblue tetrazolium (NBT) reduction test.	Nitroblue Tetrazolium	125-128	pyruvate kinase M1/2	Homo sapiens	70-74
20649094-2	2010	The present study is designed to compare and correlate modified NBT reduction method for the estimation of Glycated protein (Glycated Haemoglobin) with HbA1C estimated on DCA+2000Analyzer.	Nitroblue Tetrazolium	64-67	hemoglobin subunit alpha 1	Homo sapiens	152-156
17315258-1	2007	Mammalian mitochondrial dihydrolipoamide dehydrogenase (DLDH, EC 1.8.1.4) catalyzes NAD(+)-dependent oxidation of dihydrolipoamide in vivo and can also act as a diaphorase catalyzing in vitro nicotinamide adenine dinucleotide (reduced form) (NADH)-dependent reduction of electron-accepting molecules such as ubiquinone and nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	323-344	dihydrolipoamide dehydrogenase	Homo sapiens	56-60
19349119-3	2009	In this study the polyacrylamide gel electrophoresis (PAGE) and nitroblue tetrazolium (NBT) photoreduction methods were used to analyze the effects of GSNO on the activities of lactate dehydrogenase (LDH), glucose-6-phosphate dehydrogenase (G6PD), aconitase and superoxide dismutase (SOD).	Nitroblue Tetrazolium	64-85	ETH_00005300	Eimeria tenella	200-203
19349119-3	2009	In this study the polyacrylamide gel electrophoresis (PAGE) and nitroblue tetrazolium (NBT) photoreduction methods were used to analyze the effects of GSNO on the activities of lactate dehydrogenase (LDH), glucose-6-phosphate dehydrogenase (G6PD), aconitase and superoxide dismutase (SOD).	Nitroblue Tetrazolium	87-90	ETH_00005300	Eimeria tenella	177-198
18469441-8	2008	AT1R activation-mediated oxidative stress was assessed by changes in NADPH oxidase expression, and the level of superoxide production was determined by nitroblue tetrazolium (NBT) assay.	Nitroblue Tetrazolium	175-178	angiotensin II receptor, type 1b	Rattus norvegicus	0-4
18407056-2	2008	The PCR-RFLP technique was applied to analyze the correlation between the polymorphisms of Nramp1 gene and immune function [value of Polymorphonuclear Leukocytes (PMN) obtained by Nitroblue Tetrazolium (NBT) Reduction and effect of Cytotoxin in Monocyte] and production performance in 165 Large White pigs.	Nitroblue Tetrazolium	180-201	natural resistance associated-macrophage protein 1	Sus scrofa	91-97
18407056-2	2008	The PCR-RFLP technique was applied to analyze the correlation between the polymorphisms of Nramp1 gene and immune function [value of Polymorphonuclear Leukocytes (PMN) obtained by Nitroblue Tetrazolium (NBT) Reduction and effect of Cytotoxin in Monocyte] and production performance in 165 Large White pigs.	Nitroblue Tetrazolium	203-206	natural resistance associated-macrophage protein 1	Sus scrofa	91-97
17884519-3	2007	SOD activity was measured by the method based on nitrobluetetrazolium reduction rate.	Nitroblue Tetrazolium	49-69	superoxide dismutase 1	Homo sapiens	0-3
17501721-10	2007	Thus NOX4 probably generates O(2)(-) within an intracellular compartment that is accessible to NBT (Nitro Blue Tetrazolium), but not to DHE or ACP.	Nitroblue Tetrazolium	95-98	NADPH oxidase 4	Homo sapiens	5-9
17501721-10	2007	Thus NOX4 probably generates O(2)(-) within an intracellular compartment that is accessible to NBT (Nitro Blue Tetrazolium), but not to DHE or ACP.	Nitroblue Tetrazolium	100-122	NADPH oxidase 4	Homo sapiens	5-9
20113600-4	2009	G-6-PD activities were measured using the NBT method.	Nitroblue Tetrazolium	42-45	glucose-6-phosphate dehydrogenase	Homo sapiens	0-6
19181672-1	2009	We recently identified the X-chromosomal four and a half LIM domain gene FHL1 as the causative gene for reducing body myopathy, a disorder characterized by progressive weakness and intracytoplasmic aggregates in muscle that exert reducing activity on menadione nitro-blue-tetrazolium (NBT).	Nitroblue Tetrazolium	285-288	four and a half LIM domains 1	Homo sapiens	73-77
18300502-3	2007	RESULTS: The morphological changes showed cell differentiation characteristics; NBT reductant was significantly increased, and the number of NBT positive cells were related to dose of SPGL (in dose-dependent manner); Expression of CD11b and CD14 increased obviously.	Nitroblue Tetrazolium	141-144	integrin subunit alpha M	Homo sapiens	231-236
17315258-1	2007	Mammalian mitochondrial dihydrolipoamide dehydrogenase (DLDH, EC 1.8.1.4) catalyzes NAD(+)-dependent oxidation of dihydrolipoamide in vivo and can also act as a diaphorase catalyzing in vitro nicotinamide adenine dinucleotide (reduced form) (NADH)-dependent reduction of electron-accepting molecules such as ubiquinone and nitroblue tetrazolium (NBT).	Nitroblue Tetrazolium	346-349	dihydrolipoamide dehydrogenase	Homo sapiens	56-60
17254356-5	2007	In neuroblastoma--an embryonal tumor with biological similarities to MB--the quassinoid NBT-272 has been demonstrated to inhibit cellular proliferation and to down-regulate c-MYC protein expression.	Nitroblue Tetrazolium	88-92	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	173-178
17286914-4	2007	The effects of TBP and TRBP on the functions of human monocytes activated by TNF-alpha and IFN-gamma in vitro were detected by nitrotetrazolium blue chloride (NBT) reduction assay for evaluating respiratory burst and by RT-PCR for evaluating IL-1beta and IL-8 mRNA transcription.	Nitroblue Tetrazolium	127-157	tumor necrosis factor	Homo sapiens	77-86
17286914-4	2007	The effects of TBP and TRBP on the functions of human monocytes activated by TNF-alpha and IFN-gamma in vitro were detected by nitrotetrazolium blue chloride (NBT) reduction assay for evaluating respiratory burst and by RT-PCR for evaluating IL-1beta and IL-8 mRNA transcription.	Nitroblue Tetrazolium	127-157	interferon gamma	Homo sapiens	91-100
17286914-4	2007	The effects of TBP and TRBP on the functions of human monocytes activated by TNF-alpha and IFN-gamma in vitro were detected by nitrotetrazolium blue chloride (NBT) reduction assay for evaluating respiratory burst and by RT-PCR for evaluating IL-1beta and IL-8 mRNA transcription.	Nitroblue Tetrazolium	159-162	interferon gamma	Homo sapiens	91-100
18217407-9	2007	RESULTS: It was found that granulocyte-colony stimulating factor activates phagocytic functions of neutrophils by normalizing low values of phagocytic index and number of granulocytes, reducing dye nitroblue tetrazolium reduction and increasing the number of phagocytic cells.	Nitroblue Tetrazolium	198-219	colony stimulating factor 3	Homo sapiens	27-64
17504458-6	2007	Exogenous CaCl2 increased NBT reduction at the pollen tube tip, suggesting that Ca2+ increases the activity of pollen NOX in vivo.	Nitroblue Tetrazolium	26-29	respiratory burst oxidase homolog protein A-like	Nicotiana tabacum	118-121
16809015-6	2006	Additionally, PYY (10(-6)M) decreases NBT reduction in macrophages from 3 and 8 months old rats, and suppresses NO production in cells from 24 months old rats, albeit regardless of absence of in vivo effect of PYY on inflammation in aged rats.	Nitroblue Tetrazolium	38-41	peptide YY	Rattus norvegicus	14-17
16763214-4	2006	Inhibition of cross-linking activity of TG2 by monodansylcadaverin in these cells led to diminished nitroblue tetrazolium (NBT) positivity, production of less superoxide anion, and decreased expression of GP91PHOX, the membrane-associated subunit of NADPH oxidase.	Nitroblue Tetrazolium	100-121	transglutaminase 2, C polypeptide	Mus musculus	40-43
16763214-4	2006	Inhibition of cross-linking activity of TG2 by monodansylcadaverin in these cells led to diminished nitroblue tetrazolium (NBT) positivity, production of less superoxide anion, and decreased expression of GP91PHOX, the membrane-associated subunit of NADPH oxidase.	Nitroblue Tetrazolium	123-126	transglutaminase 2, C polypeptide	Mus musculus	40-43
16763214-5	2006	Neutrophils isolated from TG2(-/-) mice showed diminished NBT reduction capacity, reduced superoxide anion formation, and down-regulation of the gp91phox subunit of NADPH oxidase, compared with wild-type cells.	Nitroblue Tetrazolium	58-61	transglutaminase 2, C polypeptide	Mus musculus	26-29
16861049-7	2007	In addition, the vasoconstrictor actions of AVP and phenylephrine were markedly suppressed after administration of PHMBA or nitroblue tetrazolium.	Nitroblue Tetrazolium	124-145	arginine vasopressin	Rattus norvegicus	44-47
16650894-5	2006	When cells were treated with realgar in the presence of an inhibitor of PP1 and 2A or an inhibitor of PP2B, the differentiation of the cells was partially suppressed as revealed by NBT reduction assay and the expression of CD14.	Nitroblue Tetrazolium	181-184	neuropeptide Y receptor Y4	Homo sapiens	72-75
16885501-8	2006	JAK2 inhibitor suppressed induction of NBT-reducing activity in ML-1 cells treated with both reagents.	Nitroblue Tetrazolium	39-42	Janus kinase 2	Homo sapiens	0-4
16513102-3	2006	METHODS: We adapted the nitroblue tetrazolium assay to measure in micro-well plates the fructosamine content of transferrin isolated from serum by immunocomplexation.	Nitroblue Tetrazolium	24-45	transferrin	Homo sapiens	112-123
16513102-8	2006	CONCLUSIONS: These results indicate that the adapted nitroblue tetrazolium assay combined with immunocomplexation of serum transferrin is suitable to detect differences in in vivo transferrin glycation between non-diabetic, type 1 and type 2 diabetic subjects.	Nitroblue Tetrazolium	53-74	transferrin	Homo sapiens	180-191
16824780-6	2006	The induction of nitroblue tetrazolium reduction and adhesion abilities in THP-1 cells was closely correlated with the concentrations of interleukin-6 protein in the culture supernatants.	Nitroblue Tetrazolium	17-38	interleukin 6	Homo sapiens	137-150
16677835-8	2006	Based on cell morphology and NBT reduction, Tbeta4 and AcSDKP induced differentiation of HL-60 cells.	Nitroblue Tetrazolium	29-32	thymosin beta 4 X-linked	Homo sapiens	44-50
16595161-2	2006	The expression of heat shock protein was measured using a secreted alkaline phosphatase (SEAP) reporter gene transformed into HeLa cell strain, the levels of superoxide anion (O(2)(-)) and hydrogen peroxide (H(2)O(2)) were determined by NBT reduction assay and DCFH staining flow cytometry (FCM), respectively.	Nitroblue Tetrazolium	237-240	heat shock protein 90 beta family member 2, pseudogene	Homo sapiens	18-36
16800923-10	2006	Various concentrations (50, 75, 100 microg/ml) of bestatin combined with 10 nmol/L ATRA down-regulated the expression of c-Myc protein, which was negatively correlated with the NBT reduction activity of NB4 cells induced by 10 nmol/L ATRA alone or plus bestatin at various concentrations (r = -0.940, P = 0.017).	Nitroblue Tetrazolium	177-180	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	121-126
16573735-5	2006	The combined treatment of the cells with PPARgamma ligand and all-trans retinoic acid (ATRA) synergistically induced myelocytic differentiation, as determined by nitroblue tetrazolium reducing ability and cell morphology.	Nitroblue Tetrazolium	162-183	peroxisome proliferator activated receptor gamma	Homo sapiens	41-50
16129031-8	2005	This rapid down-regulation of VEGF gene expression, during ATRA-induced NB4 cell differentiation, was accompanied by the up-regulation of CD11b expression and an increased NBT reduction rate.	Nitroblue Tetrazolium	172-175	vascular endothelial growth factor A	Homo sapiens	30-34
16468360-8	2005	SDS-PAGE showed that the target protein rhSOD (19 kD) was purified homogeneously and NBT activity identification proved that the purified and renatured rhSOD had very strong SOD activity.	Nitroblue Tetrazolium	85-88	superoxide dismutase 1	Homo sapiens	42-45
16142418-3	2005	In three types of SSs, monophasic fibrous, biphasic and poorly differentiated, NBT/BCIP signals corresponding to SYT-SSX mRNA were uniformly and predominantly positive in the sarcoma cell cytoplasm.	Nitroblue Tetrazolium	79-82	synaptotagmin 1	Homo sapiens	113-116
16142418-3	2005	In three types of SSs, monophasic fibrous, biphasic and poorly differentiated, NBT/BCIP signals corresponding to SYT-SSX mRNA were uniformly and predominantly positive in the sarcoma cell cytoplasm.	Nitroblue Tetrazolium	79-82	SSX family member 2B	Homo sapiens	117-120
16532971-2	2005	METHODS: G6PD deficiency was screened by NBT method, G6PD mutations identified by amplification refractory mutation system (ARMS), mismatch-PCR with a restriction endonuclease, PCR-SSCP and DNA sequencing.	Nitroblue Tetrazolium	41-44	glucose-6-phosphate dehydrogenase	Homo sapiens	9-13
16410947-6	2005	A trend towards a positive correlation was noted, with increasing percentage of NBT positive neutrophils and levels of IFN-gamma.	Nitroblue Tetrazolium	80-83	interferon gamma	Homo sapiens	119-128
16410947-7	2005	The high IFN-gamma producing HTLV-1 patient group had significantly greater NBT than healthy controls, 43+/-24% and 17+/-4.8% respectively (p< 0.001), while no significant difference was observed between healthy controls and the low IFN-gamma-producing HTLV-1 patient group (30+/-20%).	Nitroblue Tetrazolium	76-79	interferon gamma	Homo sapiens	9-18
16422374-6	2005	GCD was suggested and confirmed by the NBT test.	Nitroblue Tetrazolium	39-42	guanylate cyclase 2E, pseudogene	Homo sapiens	0-3
16316409-8	2005	As CRABPI was elevated far more than any other genes, we observed that the retinoids, all-trans retinoic acid and 9-cis retinoic acid, that bind CRABPI, promoted nitroblue tetrazolium-associated functional cell differentiation in p75NTR PC-3 cells, but not in neo control PC-3 cells.	Nitroblue Tetrazolium	162-183	cellular retinoic acid binding protein 1	Homo sapiens	3-9
16316409-8	2005	As CRABPI was elevated far more than any other genes, we observed that the retinoids, all-trans retinoic acid and 9-cis retinoic acid, that bind CRABPI, promoted nitroblue tetrazolium-associated functional cell differentiation in p75NTR PC-3 cells, but not in neo control PC-3 cells.	Nitroblue Tetrazolium	162-183	cellular retinoic acid binding protein 1	Homo sapiens	145-151
16316409-8	2005	As CRABPI was elevated far more than any other genes, we observed that the retinoids, all-trans retinoic acid and 9-cis retinoic acid, that bind CRABPI, promoted nitroblue tetrazolium-associated functional cell differentiation in p75NTR PC-3 cells, but not in neo control PC-3 cells.	Nitroblue Tetrazolium	162-183	nerve growth factor receptor	Homo sapiens	230-236
16081252-5	2005	Incubation of SDS-PAGE gel with BCIP/NBT dye clearly showed that the expression of ALP in tumor renal BBM was markedly reduced as compared to normal kidney.	Nitroblue Tetrazolium	37-40	ATHS	Homo sapiens	83-86
15738610-7	2005	Nitroblue tetrazolium dye test was used for G6PD deficiency screening and quantitative assay for measurement of G6PD enzyme activity.	Nitroblue Tetrazolium	0-21	glucose-6-phosphate dehydrogenase	Homo sapiens	44-48
15750262-5	2004	Treatment with genistein also remarkably reduced the Ang II-induced superoxide by the reduction of nitroblue tetrazolium, inhibited nitrotyrosine formation, and attenuated endothelin-1 production by ELISA via the stimulation of Ang II.	Nitroblue Tetrazolium	99-120	angiotensinogen	Rattus norvegicus	53-59
15476381-11	2004	The complexes exhibit high SOD activity, as shown by the low IC(50) values obtained with the xanthine/xanthine oxidase/NBT assay: 0.13 microM for compound 1; 0.17 microM for compound 2.	Nitroblue Tetrazolium	119-122	superoxide dismutase 1	Homo sapiens	27-30
15711098-5	2005	METHODS: The total plasma SOD activity was determined by the nitroblue tetrazolium method, plasma SOD contents by ELISA, and SOD mRNA levels in leukocytes by RT-PCR.	Nitroblue Tetrazolium	61-82	superoxide dismutase 1	Homo sapiens	26-29
15634573-5	2004	When ATRA + SQ22536 group compared with ATRA group, the positivity of CD11b decreased from (95.9 +/- 2.5)% to (60.3 +/- 7.1)%, while the A(540) in NBT reduction assay decreased from 0.585 +/- 0.092 to 0.170 +/- 0.028 (P < 0.05).	Nitroblue Tetrazolium	147-150	integrin subunit alpha M	Homo sapiens	70-75
15634573-7	2004	When ATRA + forskolin group compared with ATRA group, the positivity of CD11b increased from (34.3 +/- 5.3)% to (94.6 +/- 2.4)%, while the A(540) in NBT reduction assay increased from 0.110 +/- 0.028 to 0.395 +/- 0.049 (P < 0.05).	Nitroblue Tetrazolium	149-152	integrin subunit alpha M	Homo sapiens	72-77
14718401-5	2004	Myocardial ET-1 peptide levels were significantly increased in binary transgenic (BT, ET+/tTA+) compared with nonbinary transgenic (NBT, ET+/tTA-; ET-/tTA+; ET-/tTA-) or DOX-treated BT littermates (40.1+/-4.7 versus 2.6+/-1.2 fmol/mL, P<0.003).	Nitroblue Tetrazolium	132-135	endothelin 1	Mus musculus	11-15
15129738-3	2004	SOD activity was evaluated by both the nitroblue tetrazolium (NBT) reduction assay and electron paramagnetic resonance (EPR) with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) as a spin trapping agent.	Nitroblue Tetrazolium	39-60	superoxide dismutase 1	Homo sapiens	0-3
15129738-3	2004	SOD activity was evaluated by both the nitroblue tetrazolium (NBT) reduction assay and electron paramagnetic resonance (EPR) with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) as a spin trapping agent.	Nitroblue Tetrazolium	62-65	superoxide dismutase 1	Homo sapiens	0-3
14712293-5	2004	Phenotypic characterization of the clones revealed that BCR/ABL induces a slight decrease in the proliferation and viability, without a marked effect on cell cycle distribution, the rate of apoptosis or on cellular differentiation, as judged by several cell surface markers and capacity to reduce nitro blue tetrazolium.	Nitroblue Tetrazolium	297-319	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	56-63
14732485-4	2004	The transient decrease in the nuclear PARG activity by TPA treatment was accompanied by differentiation as measured by the nitroblue tetrazolium (NBT) reducing activity and adhesion to the culture dishes.	Nitroblue Tetrazolium	123-144	poly(ADP-ribose) glycohydrolase	Homo sapiens	38-42
14732485-4	2004	The transient decrease in the nuclear PARG activity by TPA treatment was accompanied by differentiation as measured by the nitroblue tetrazolium (NBT) reducing activity and adhesion to the culture dishes.	Nitroblue Tetrazolium	146-149	poly(ADP-ribose) glycohydrolase	Homo sapiens	38-42
12951068-3	2003	Computer-assisted morphometry of the ischaemic reperfused hearts stained with nitroblue tetrazolium showed the extension of damaged myocardium (area at risk and infarct size) significantly reduced in rats treated with histaminase, in comparison with the non-treated rats, whereas no protection was found with the semicarbazide inactivated histaminase.	Nitroblue Tetrazolium	78-99	amine oxidase, copper containing 1	Rattus norvegicus	218-229
12951068-3	2003	Computer-assisted morphometry of the ischaemic reperfused hearts stained with nitroblue tetrazolium showed the extension of damaged myocardium (area at risk and infarct size) significantly reduced in rats treated with histaminase, in comparison with the non-treated rats, whereas no protection was found with the semicarbazide inactivated histaminase.	Nitroblue Tetrazolium	78-99	amine oxidase, copper containing 1	Rattus norvegicus	339-350
12811016-4	2003	The nitrocellulose sheet was successively incubated with human sera known to contain IgE that binds to rapeseed proteins, alkaline phosphatase-conjugated goat anti-human IgE and 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium.	Nitroblue Tetrazolium	219-240	immunoglobulin heavy constant epsilon	Homo sapiens	85-88
13678532-4	2003	Ang II significantly stimulated superoxide formation in monocytes, as measured by nitro blue tetrazolium reduction assay, as well as the chemotactic response to MCP-1 with the increased expression of CCR2 determined by RT-PCR and western blotting analysis.	Nitroblue Tetrazolium	82-104	angiotensinogen	Homo sapiens	0-6
14642183-2	2003	METHODS: By using U937 cell line as a model, the induced differentiation of MTX or GM-CSF or their combination was detected by NBT reduction test, morphological observation and CD(14) expression.	Nitroblue Tetrazolium	127-130	metaxin 1	Homo sapiens	76-79
14642183-2	2003	METHODS: By using U937 cell line as a model, the induced differentiation of MTX or GM-CSF or their combination was detected by NBT reduction test, morphological observation and CD(14) expression.	Nitroblue Tetrazolium	127-130	colony stimulating factor 2	Homo sapiens	83-89
12880368-5	2003	NaF at subtoxic concentrations (<0.5 mM) significantly up-regulated activities of several intracellular enzymes (lactate dehydrogenase, beta-glucuronidase, acid phosphatase), cellular reduction of nitroblue tetrazolium, and nitric oxide (NO) production; which are all accepted as general differentiation markers.	Nitroblue Tetrazolium	200-221	C-X-C motif chemokine ligand 8	Homo sapiens	0-3
12677525-3	2003	The ability of HL-60 cells to reduce nitroblue tetrazolium (NBT) was significantly increased after APC treatment for 72 h. In these differentiating HL-60 cells, cell surface differentiation markers CD11b (for myeloid cells) and CD14 (for monocytic cells) were detected in 90.3 % and 70.1 % of the cells, respectively.	Nitroblue Tetrazolium	37-58	CD14 molecule	Homo sapiens	228-232
12677525-3	2003	The ability of HL-60 cells to reduce nitroblue tetrazolium (NBT) was significantly increased after APC treatment for 72 h. In these differentiating HL-60 cells, cell surface differentiation markers CD11b (for myeloid cells) and CD14 (for monocytic cells) were detected in 90.3 % and 70.1 % of the cells, respectively.	Nitroblue Tetrazolium	60-63	integrin subunit alpha M	Homo sapiens	198-203
12677525-3	2003	The ability of HL-60 cells to reduce nitroblue tetrazolium (NBT) was significantly increased after APC treatment for 72 h. In these differentiating HL-60 cells, cell surface differentiation markers CD11b (for myeloid cells) and CD14 (for monocytic cells) were detected in 90.3 % and 70.1 % of the cells, respectively.	Nitroblue Tetrazolium	60-63	CD14 molecule	Homo sapiens	228-232
12045229-12	2002	Finally, coexpression of active Rac1 and active MEK1 induced the motility of NBT-II cells, suggesting that Ras mediates NBT-II cell scattering through the coordinate activation of Rac and the Raf/MAPK pathway.	Nitroblue Tetrazolium	77-80	Rac family small GTPase 1	Rattus norvegicus	32-36
12399974-6	2002	SS (400 microg/ml, 6 days) induced 60% and 55% of NBT-positive cells in HL-60 and U937 cell lines, which were augmented in the presence of GM-CSF (25 ng/ml) to levels (85% and 81%, respectively) comparable to those induced by ATRA.	Nitroblue Tetrazolium	50-53	colony stimulating factor 2	Homo sapiens	139-145
12324654-7	2002	Retinoic acid also induced a higher percentage of functionally differentiated blr1 transfectants as assessed by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	112-133	C-X-C motif chemokine receptor 5	Homo sapiens	78-82
12389121-5	2002	SOD-like activity was measured as the inhibition of nitroblue tetrazolium reduction due to superoxide anion generation by xanthine plus xanthine oxidase.	Nitroblue Tetrazolium	52-73	superoxide dismutase 1	Homo sapiens	0-3
12624657-6	2003	With the addition of THP at 500 nM, there was a significant decrease in the release of LDH and the production of MDA and NBT.	Nitroblue Tetrazolium	121-124	uromodulin	Canis lupus familiaris	21-24
12225656-3	2002	Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O(-)(2) generation.	Nitroblue Tetrazolium	39-60	superoxide dismutase 1	Homo sapiens	0-20
12225656-3	2002	Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O(-)(2) generation.	Nitroblue Tetrazolium	39-60	superoxide dismutase 1	Homo sapiens	22-25
12225656-3	2002	Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O(-)(2) generation.	Nitroblue Tetrazolium	62-65	superoxide dismutase 1	Homo sapiens	0-20
12225656-3	2002	Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O(-)(2) generation.	Nitroblue Tetrazolium	62-65	superoxide dismutase 1	Homo sapiens	22-25
12225656-5	2002	FPI increased SOD-inhibitable NBT reduction, but pretreatment with norbinaltorphimine, a dynorphin antagonist, or NS398, a COX-2 inhibitor, blunted such reduction (1 +/- 1 vs. 19 +/- 3 vs. 4 +/- 1 vs. 4 +/- 1 pmol/mm(2) for control, FPI, FPI-norbinaltorphimine and FPI-NS398, respectively).	Nitroblue Tetrazolium	30-33	superoxide dismutase 1	Homo sapiens	14-17
12225656-6	2002	Under non-brain injury conditions, dynorphin, in a concentration observed in CSF after FPI, also increased SOD-inhibitable NBT reduction, which was blunted by NS398.	Nitroblue Tetrazolium	123-126	superoxide dismutase 1	Homo sapiens	107-110
12045229-12	2002	Finally, coexpression of active Rac1 and active MEK1 induced the motility of NBT-II cells, suggesting that Ras mediates NBT-II cell scattering through the coordinate activation of Rac and the Raf/MAPK pathway.	Nitroblue Tetrazolium	77-80	mitogen activated protein kinase kinase 1	Rattus norvegicus	48-52
12045229-12	2002	Finally, coexpression of active Rac1 and active MEK1 induced the motility of NBT-II cells, suggesting that Ras mediates NBT-II cell scattering through the coordinate activation of Rac and the Raf/MAPK pathway.	Nitroblue Tetrazolium	120-123	Rac family small GTPase 1	Rattus norvegicus	32-36
12045229-12	2002	Finally, coexpression of active Rac1 and active MEK1 induced the motility of NBT-II cells, suggesting that Ras mediates NBT-II cell scattering through the coordinate activation of Rac and the Raf/MAPK pathway.	Nitroblue Tetrazolium	120-123	mitogen activated protein kinase kinase 1	Rattus norvegicus	48-52
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	43-49
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
12545210-3	2002	From the square-wave voltammetry of native PPO II, peroxide-PPO II complex and azide-PPO II complex, the reduction of nitro blue tetrazolium by the enzymes and activation of PPO II by peroxide it follows that the binding of azide to PPO II induces the formation of CuO(2)(2-)Cu in the active site of PPO II from CuO(2)(-)Cu in native PPO II.	Nitroblue Tetrazolium	118-140	protoporphyrinogen oxidase, mitochondrial	Nicotiana tabacum	60-66
11750096-5	2001	The effect of introduction of p16(INK4A) on capacity for induced differentiation, assayed by capacity to reduce nitroblue tetrazolium, was determined.	Nitroblue Tetrazolium	112-133	cyclin dependent kinase inhibitor 2A	Homo sapiens	30-33
11750096-5	2001	The effect of introduction of p16(INK4A) on capacity for induced differentiation, assayed by capacity to reduce nitroblue tetrazolium, was determined.	Nitroblue Tetrazolium	112-133	cyclin dependent kinase inhibitor 2A	Homo sapiens	34-39
11250656-7	2001	In addition, HOXB4 antisense partially blocked 1,25-(OH)2D(3)-mediated decrease in c-myc levels (46+/-6% inhibition) and promotion of HL-60 cell differentiation (20+/-2% and 25+/-3% inhibition as assessed by nitroblue tetrazolium and non-specific esterase assays respectively).	Nitroblue Tetrazolium	208-229	homeobox B4	Homo sapiens	13-18
20954153-3	2001	Activity can be measured as described in this unit by a number of indirect competitive inhibition assays based on the principle that the superoxide anion radical will reduce an inhibitory substrate [such as nitroblue tetrazolium (NBT) or cytochrome c] and SOD activity will reduce the rate of reduction in a competitive fashion.	Nitroblue Tetrazolium	230-233	superoxide dismutase 2	Homo sapiens	256-259
11290591-7	2001	After overexpression of PU.1, MEL cells became adherent and phagocytic and showed enhanced nitroblue tetrazolium reduction activity.	Nitroblue Tetrazolium	91-112	spleen focus forming virus (SFFV) proviral integration oncogene	Mus musculus	24-28
11686491-3	2001	Under non-brain injury conditions, topical ET-1 (10(-10) M, the concentration present in CSF following FPI) increased SOD-inhibitable NBT reduction from 1 +/- 1 to 17 +/- 3 pmol/mm2.	Nitroblue Tetrazolium	134-137	endothelin-1	Sus scrofa	43-47
11489250-3	2001	Under non-brain injury conditions, topical vasopressin (40 pg/ml, the concentration present in CSF following FPI) increased SOD inhibitable NBT reduction from 1+/-1 to 25+/-4 pmol/mm(2).	Nitroblue Tetrazolium	140-143	vasopressin	Sus scrofa	43-54
11500544-3	2001	Addition of PA promoted the synthesis of superoxide in the PLD alpha-depleted plants, as measured by chemiluminescence and superoxide dismutase-inhibitable, NADPH-dependent reduction of cytochrome c and nitroblue tetrazolium.	Nitroblue Tetrazolium	203-224	phospholipase D alpha 1	Arabidopsis thaliana	59-62
11387506-8	2001	RESULTS: Under sham injury conditions, topical vasopressin (40 pg/mL, the concentration present in CSF after FPI) increased superoxide dismutase-inhibitable NBT reduction from 1+/-1 to 23+/-4 pmol/mm(2).	Nitroblue Tetrazolium	157-160	vasopressin	Sus scrofa	47-58
10893205-5	2000	Additionally, neutrophils recovered from the lung lavage fluid of rats given IL-1 intratracheally reduced more nitro blue tetrazolium (NBT) in vitro than neutrophils recovered from control rats or rats that had been given WEB-2086 and then IL-1.	Nitroblue Tetrazolium	111-133	interleukin 1 alpha	Homo sapiens	77-81
11054668-5	2000	As measured by expressions of differentiation markers and the functional assessment of the ability to reduce nitroblue-tetrazolium, our results further showed that over-expression of nucleophosmin/B23 decreased the response of the cells to RA-induced differentiation.	Nitroblue Tetrazolium	109-130	nucleophosmin 1	Homo sapiens	183-196
11054668-5	2000	As measured by expressions of differentiation markers and the functional assessment of the ability to reduce nitroblue-tetrazolium, our results further showed that over-expression of nucleophosmin/B23 decreased the response of the cells to RA-induced differentiation.	Nitroblue Tetrazolium	109-130	nucleophosmin 1	Homo sapiens	197-200
11374170-5	2000	About 56% of HL-60 cells exposed to c-myc AS-ODN/lipofectin complex were NBT-positive and showed morphological changes with differentiated phenotype compared with 29% of untreated cells.	Nitroblue Tetrazolium	73-76	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	36-41
10893205-5	2000	Additionally, neutrophils recovered from the lung lavage fluid of rats given IL-1 intratracheally reduced more nitro blue tetrazolium (NBT) in vitro than neutrophils recovered from control rats or rats that had been given WEB-2086 and then IL-1.	Nitroblue Tetrazolium	135-138	interleukin 1 alpha	Homo sapiens	77-81
10848831-9	2000	All NADPH oxidase subunits were constitutively present, but nitroblue tetrazolium reduction was only detectable upon activation with IFN-gamma.	Nitroblue Tetrazolium	60-81	interferon gamma	Homo sapiens	133-142
11108571-5	2000	G-CSF caused the transformants expressing G-CSFR to display a morphological characteristic of mature granulocytes, upregulated CD11b on the cell surface, and improved NBT reduction activity.	Nitroblue Tetrazolium	167-170	colony stimulating factor 3	Homo sapiens	0-5
11108571-5	2000	G-CSF caused the transformants expressing G-CSFR to display a morphological characteristic of mature granulocytes, upregulated CD11b on the cell surface, and improved NBT reduction activity.	Nitroblue Tetrazolium	167-170	colony stimulating factor 3 receptor	Homo sapiens	42-48
10394165-12	1999	In a comparison of patient groups across the CEAP classes, the NBT-positive granulocyte counts were significantly greater in classes 4, 5, and 6 than in classes 2 and 3 (P <.001).	Nitroblue Tetrazolium	63-66	biogenesis of lysosomal organelles complex 1 subunit 2	Homo sapiens	45-49
10696106-3	2000	NBT altered the frequency distribution of BK channel open times from a two exponential to a single exponential form.	Nitroblue Tetrazolium	0-3	potassium calcium-activated channel subfamily M alpha 1	Rattus norvegicus	42-52
10696106-7	2000	The combined effects of internal NBT on mean open and closed times resulted in the suppression of BK channel open probability when measured at positive membrane potentials.	Nitroblue Tetrazolium	33-36	potassium calcium-activated channel subfamily M alpha 1	Rattus norvegicus	98-108
10696106-10	2000	Externally applied NBT suppressed BK channel open probability at concentrations which also inhibit nitric oxide synthase (NOS).	Nitroblue Tetrazolium	19-22	potassium calcium-activated channel subfamily M alpha 1	Rattus norvegicus	34-44
10698209-8	2000	In LS, the NBT reaction revealed evidence of superoxide production associated with CD68+HLA-DR+ cells.	Nitroblue Tetrazolium	11-14	CD68 molecule	Homo sapiens	83-87
10684960-4	1999	When the HL60 cell line expressing the mutant MEF2D was induced to differentiate by VitD(3) treatment, cell surface expression of CD14 and the ability to reduce NBT, which are important characteristics of differentiated monocytes, were significantly decreased compared with control HL60 cells.	Nitroblue Tetrazolium	161-164	myocyte enhancer factor 2D	Homo sapiens	46-51
9880243-3	1998	The nitroblue tetrazolium (NBT) test of NADPH oxidase activity was used to screen transduced cells for vector-mediated expression of recombinant gp91phox.	Nitroblue Tetrazolium	4-25	cytochrome b-245 beta chain	Homo sapiens	145-153
11127803-4	1999	Preincubation of intact human neutrophils with INF-alpha and subsequent stimulation with calcium ionophore A23187 also enhanced significantly superoxide radical generation that reduced nitroblue tetrazolium into blue formazan.	Nitroblue Tetrazolium	185-206	interferon alpha 17	Homo sapiens	47-56
10339483-2	1999	Exposure of WEHI-3B D+ myelomonocytic leukemia and myeloid LGM-1 cells overexpressing the G-CSFR to G-CSF resulted in induction of differentiation as measured by (1) the ability to reduce nitroblue tetrazolium (NBT), (2) the expression of Mac-I antigen, and (3) the expression of FcgammaII/III receptor.	Nitroblue Tetrazolium	188-209	colony stimulating factor 3 receptor	Homo sapiens	90-96
10339483-2	1999	Exposure of WEHI-3B D+ myelomonocytic leukemia and myeloid LGM-1 cells overexpressing the G-CSFR to G-CSF resulted in induction of differentiation as measured by (1) the ability to reduce nitroblue tetrazolium (NBT), (2) the expression of Mac-I antigen, and (3) the expression of FcgammaII/III receptor.	Nitroblue Tetrazolium	188-209	colony stimulating factor 3	Homo sapiens	90-95
10339483-2	1999	Exposure of WEHI-3B D+ myelomonocytic leukemia and myeloid LGM-1 cells overexpressing the G-CSFR to G-CSF resulted in induction of differentiation as measured by (1) the ability to reduce nitroblue tetrazolium (NBT), (2) the expression of Mac-I antigen, and (3) the expression of FcgammaII/III receptor.	Nitroblue Tetrazolium	211-214	colony stimulating factor 3 receptor	Homo sapiens	90-96
10339483-2	1999	Exposure of WEHI-3B D+ myelomonocytic leukemia and myeloid LGM-1 cells overexpressing the G-CSFR to G-CSF resulted in induction of differentiation as measured by (1) the ability to reduce nitroblue tetrazolium (NBT), (2) the expression of Mac-I antigen, and (3) the expression of FcgammaII/III receptor.	Nitroblue Tetrazolium	211-214	colony stimulating factor 3	Homo sapiens	90-95
10337917-8	1999	Equal to the CL technique, nitroblue tetrazolium (NBT) staining of RAW 264.7 showed SOD-inhibitable formazan precipitation when stimulated with pneumococci.	Nitroblue Tetrazolium	27-48	superoxide dismutase 1	Homo sapiens	84-87
10337917-8	1999	Equal to the CL technique, nitroblue tetrazolium (NBT) staining of RAW 264.7 showed SOD-inhibitable formazan precipitation when stimulated with pneumococci.	Nitroblue Tetrazolium	50-53	superoxide dismutase 1	Homo sapiens	84-87
9952315-4	1999	RXR agonists alone induced nitroblue tetrazolium (NBT) reduction and expression of CD11b in U937 cells, whereas RAR agonists alone did not.	Nitroblue Tetrazolium	27-48	retinoid X receptor alpha	Homo sapiens	0-3
9952315-4	1999	RXR agonists alone induced nitroblue tetrazolium (NBT) reduction and expression of CD11b in U937 cells, whereas RAR agonists alone did not.	Nitroblue Tetrazolium	50-53	retinoid X receptor alpha	Homo sapiens	0-3
9880243-3	1998	The nitroblue tetrazolium (NBT) test of NADPH oxidase activity was used to screen transduced cells for vector-mediated expression of recombinant gp91phox.	Nitroblue Tetrazolium	27-30	cytochrome b-245 beta chain	Homo sapiens	145-153
9588900-4	1998	To this purpose, rats were treated with carbon tetrachloride (CCl4) and livers subjected to in situ perfusion with nitroblue tetrazolium, which, in the presence of superoxide ions, is reduced to an insoluble blue-colored formazan derivative and is readily detectable in the tissue by light microscopy.	Nitroblue Tetrazolium	115-136	C-C motif chemokine ligand 4	Rattus norvegicus	62-66
18425640-2	1998	After incubation with 200 U/mL IL-12 for 48 h, DNA synthesis of FBL-3 cells in S phase decreased significantly; the expression of CD14 which is the specific marker of monocyte increased, the rate of NBT(+) cells was apparently higher than that of the untreated FBL-3 cells.	Nitroblue Tetrazolium	199-202	F-box and leucine rich repeat protein 3	Homo sapiens	64-69
18425640-2	1998	After incubation with 200 U/mL IL-12 for 48 h, DNA synthesis of FBL-3 cells in S phase decreased significantly; the expression of CD14 which is the specific marker of monocyte increased, the rate of NBT(+) cells was apparently higher than that of the untreated FBL-3 cells.	Nitroblue Tetrazolium	199-202	CD14 molecule	Homo sapiens	130-134
18425640-2	1998	After incubation with 200 U/mL IL-12 for 48 h, DNA synthesis of FBL-3 cells in S phase decreased significantly; the expression of CD14 which is the specific marker of monocyte increased, the rate of NBT(+) cells was apparently higher than that of the untreated FBL-3 cells.	Nitroblue Tetrazolium	199-202	F-box and leucine rich repeat protein 3	Homo sapiens	261-266
9767552-1	1998	BACKGROUND: Nitroblue tetrazolium (NBT) reduction to formazan has been used as a marker for nitric oxide synthase (NOS).	Nitroblue Tetrazolium	12-33	nitric oxide synthase 2	Homo sapiens	92-113
9767552-1	1998	BACKGROUND: Nitroblue tetrazolium (NBT) reduction to formazan has been used as a marker for nitric oxide synthase (NOS).	Nitroblue Tetrazolium	35-38	nitric oxide synthase 2	Homo sapiens	92-113
9767552-9	1998	Superoxide dismutase/catalase decreased NBT reduction.	Nitroblue Tetrazolium	40-43	catalase	Homo sapiens	21-29
9617758-4	1998	SIN-1 reduced nitro blue tetrazolium and the effect was inhibitable by superoxide dismutase.	Nitroblue Tetrazolium	14-36	MAPK associated protein 1	Homo sapiens	0-5
9572303-7	1998	Sensitivity of the nitroblue tetrazolium reduction to superoxide dismutase indicated that the reduction of LY 83583 by NAD(P)H:quinone oxidoreductase leads to superoxide generation.	Nitroblue Tetrazolium	19-40	crystallin zeta	Homo sapiens	127-149
9605667-6	1998	Quantification for eIF4E protein level was accomplished using a rabbit anti-eIF4E antibody and colorimetric development of Western blots using nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.	Nitroblue Tetrazolium	143-165	eukaryotic translation initiation factor 4E	Homo sapiens	19-24
9617758-5	1998	Reduction of nitro blue tetrazolium was not detected in the solutions of GEA 3162 and S-nitroso-N-acetylpenicillamine suggesting that SIN-1 but not GEA 3162 and S-nitroso-N-acetylpenicillamine release O2.- in their decomposition process.	Nitroblue Tetrazolium	13-35	MAPK associated protein 1	Homo sapiens	134-139
9327726-8	1997	The CYP2A5 immunohistochemical staining co-localized with formazan deposits resulting from nitro blue tetrazolium reduction and occurred in nuclei as well as cytoplasm.	Nitroblue Tetrazolium	91-113	cytochrome P450, family 2, subfamily a, polypeptide 5	Mus musculus	4-10
9459619-8	1997	In the rIFN-gamma group, toxicity was mild and some biological changes were seen (NK/LAK activation, increase of phagocytosis and of NBT reduction).	Nitroblue Tetrazolium	133-136	interferon gamma	Rattus norvegicus	7-17
9579370-8	1998	The known tumor suppressor genes retinoblastoma (RB) and p53 showed loss of expression in GMTT compared with NBT.	Nitroblue Tetrazolium	109-112	RB transcriptional corepressor 1	Homo sapiens	33-47
9579370-8	1998	The known tumor suppressor genes retinoblastoma (RB) and p53 showed loss of expression in GMTT compared with NBT.	Nitroblue Tetrazolium	109-112	RB transcriptional corepressor 1	Homo sapiens	49-51
9579370-8	1998	The known tumor suppressor genes retinoblastoma (RB) and p53 showed loss of expression in GMTT compared with NBT.	Nitroblue Tetrazolium	109-112	tumor protein p53	Homo sapiens	57-60
9493559-9	1998	Nitroblue tetrazolium-reducing mononuclear cells were CD68 or RFD7 positive but they were rarely positive for HLA-DR and RFD1.	Nitroblue Tetrazolium	0-21	CD68 molecule	Homo sapiens	54-58
9395219-7	1997	Perfusion of liver with nitroblue tetrazolium, an indicator for superoxide formation, demonstrated that in livers of infected mice, hepatocytes often co-expressed CYP2A5 and formazan deposition.	Nitroblue Tetrazolium	24-45	cytochrome P450, family 2, subfamily a, polypeptide 5	Mus musculus	163-169
27406670-1	1996	Using various superoxide generating systems and nitroblue tetrazolium or cytochrome c as superoxide detector molecules it is possible to assess the superoxide dismutase activity of proteins.	Nitroblue Tetrazolium	48-69	superoxide dismutase 1	Homo sapiens	148-168
9216650-2	1997	ATRA alone caused only slight induction of NBT-reducing activity even at a high concentration (10(-7) M), but when combined with GM-CSF, it led to remarkable increase in the induction of NBT-reducing activity.	Nitroblue Tetrazolium	187-190	colony stimulating factor 2	Homo sapiens	129-135
8978280-11	1997	Long-term exposure (5 days) of HL-60 cells to IFN-gamma caused an increase in nitroblue tetrazolium (NBT)-reducing and nonspecific esterase (NSE) activity and induced expression of Fc gamma RI (CD64) without significant effects on cell number, adherence, or phagocytic activity.	Nitroblue Tetrazolium	101-104	interferon gamma	Homo sapiens	46-55
9073351-3	1997	This is followed by specific counterstaining of glutathione reductase with dichlorophenolindophenol/nitroblue tetrazolium.	Nitroblue Tetrazolium	100-121	glutathione-disulfide reductase	Homo sapiens	48-69
9112257-1	1997	Treatment of human promyelocytic leukemia HL-60 cells with 10 muM curcumin for 48 h inhibited cellular proliferation and induced small increases in differentiation (100-200%) as measured by the proportion of cells that reduced nitroblue tetrazolium (NBT) and expressed Mac-1.	Nitroblue Tetrazolium	227-248	latexin	Homo sapiens	62-65
9112257-1	1997	Treatment of human promyelocytic leukemia HL-60 cells with 10 muM curcumin for 48 h inhibited cellular proliferation and induced small increases in differentiation (100-200%) as measured by the proportion of cells that reduced nitroblue tetrazolium (NBT) and expressed Mac-1.	Nitroblue Tetrazolium	250-253	latexin	Homo sapiens	62-65
8996511-10	1997	Topical ET-1 (10(-10) mol/L) increased SOD-inhibitable NBT reduction from 1 +/- 1 to 16 +/- 3 pmol/mm2, similar to previously reported NBT reduction after FPI (14 +/- 2 pmol/mm2).	Nitroblue Tetrazolium	55-58	endothelin-1	Sus scrofa	8-12
8996511-11	1997	BQ123 (10(-6) mol/L), an ET-1 antagonist, blunted the NBT reduction observed after FPI (4 +/- 1 pmol/mm2).	Nitroblue Tetrazolium	54-57	endothelin-1	Sus scrofa	25-29
8915775-3	1996	NaF increased cellular reduction of nitroblue tetrazolium (NBT), and this effect was strongly augmented by 1,25(OH)2D3.	Nitroblue Tetrazolium	36-57	C-X-C motif chemokine ligand 8	Homo sapiens	0-3
8915775-3	1996	NaF increased cellular reduction of nitroblue tetrazolium (NBT), and this effect was strongly augmented by 1,25(OH)2D3.	Nitroblue Tetrazolium	59-62	C-X-C motif chemokine ligand 8	Homo sapiens	0-3
8915775-10	1996	Indomethacin completely blocked stimulation of NBT reduction, NO production, and iNOS expression induced by NaF plus 1,25(OH)2D3; adding exogenous PGE2 (0.1-10 ng/ml) to these indomethacin-blocked cultures dose-dependently restored NO production.	Nitroblue Tetrazolium	47-50	C-X-C motif chemokine ligand 8	Homo sapiens	108-111
8839832-13	1996	Overexpression of the CD30v induced differentiation of HL-60 cells as evidenced by an increased NBT reduction activity.	Nitroblue Tetrazolium	96-99	TNF receptor superfamily member 8	Homo sapiens	22-26
8743726-5	1996	Thus, nitrotetrazolium blue strongly inhibited the activity of plasmin, urokinase (fibrinolytic activity), papain and pepsin.	Nitroblue Tetrazolium	6-27	plasminogen	Homo sapiens	63-70
8806808-2	1996	Reduction of nitroblue tetrazolium by stimulated tonsillar B cells is inhibited by superoxide dismutase (SOD).	Nitroblue Tetrazolium	13-34	superoxide dismutase 1	Homo sapiens	83-103
8806808-2	1996	Reduction of nitroblue tetrazolium by stimulated tonsillar B cells is inhibited by superoxide dismutase (SOD).	Nitroblue Tetrazolium	13-34	superoxide dismutase 1	Homo sapiens	105-108
8635162-3	1996	SOD was assayed using a modification of the indirect nitroblue tetrazolium assay method, while CAT was measured by a spectrophotometric method.	Nitroblue Tetrazolium	53-74	superoxide dismutase 1	Homo sapiens	0-3
8853896-5	1996	More importantly, C-JUN AS oligonucleotides showed distinct effects on two markers of PMA-induced differentiation; the C-JUN AS oligonucleotides inhibited cell adhesion, whereas they did not affect another marker of differentiation, respiratory burst (measured by nitro blue tetrazolium reduction assay).	Nitroblue Tetrazolium	264-286	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	18-23
8590308-0	1995	Inhibition of vitamin D3-induced cell differentiation by interferon-gamma in HL-60 cells determined by a nitroblue tetrazolium reduction test.	Nitroblue Tetrazolium	105-126	interferon gamma	Homo sapiens	57-73
8740254-2	1996	METHODS: Nitro blue tetrazolium (NBT) staining, a marker of reductants which may be induced by free radicals such as superoxide, and catalase activity, as an indirect measure of hydrogen peroxide (H2O2) generation, were studied in the rat retina in three conditions known to cause diabetes-like retinopathy, i.e. rats with spontaneous diabetes (the BB Wistar rat), rats with streptozotocin-induced diabetes mellitus, and rats fed on galactose.	Nitroblue Tetrazolium	33-36	catalase	Rattus norvegicus	133-141
8611027-4	1996	Spectroscopic studies indicated NADH:molecular oxygen reductase activity resulted in the production of the superoxide radical, detected as the formation of adrenochrome from epinephrine and by the formation of adrenochrome from epinephrine and by the reduction of nitroblue tetrazolium, both of which could be inhibited by the addition of superoxide dismutase and were unaffected by the addition of catalase.	Nitroblue Tetrazolium	264-285	catalase	Homo sapiens	399-407
8852433-3	1996	Here, the distribution of dihydroorotate dehydrogenase activity in cryostat sections of various rat tissues, and tissue samples of human skin and kidney, was visualized by light microscopy using the nitroblue tetrazolium technique.	Nitroblue Tetrazolium	199-220	dihydroorotate dehydrogenase	Mus musculus	26-54
8852433-7	1996	Dihydroorotate dehydrogenase and succinate dehydrogenase activity in Ehrlich ascites tumor cells grown in suspension culture were quantified by application of nitroblue tetrazolium or cyanotolyl tetrazolium and subsequent extraction of the insoluble formazans with organic solvents.	Nitroblue Tetrazolium	159-180	dihydroorotate dehydrogenase	Mus musculus	0-28
8532118-8	1995	The qualitative localization of the enzyme activity on non SDS-PAGE by nitroblue tetrazolium staining confirmed the increase of MAO-B during the development.	Nitroblue Tetrazolium	71-92	monoamine oxidase B	Rattus norvegicus	128-133
7549963-0	1995	Spectrophotometric assay for superoxide dismutase based on the nitroblue tetrazolium reduction by glucose-glucose oxidase.	Nitroblue Tetrazolium	63-84	superoxide dismutase 1	Homo sapiens	29-49
8578193-8	1995	Nitroblue tetrazolium reducing vessels were increased in inflamed mucosa, and these vessels expressed ICAM-1 and CD31.	Nitroblue Tetrazolium	0-21	intercellular adhesion molecule 1	Homo sapiens	102-108
8578193-8	1995	Nitroblue tetrazolium reducing vessels were increased in inflamed mucosa, and these vessels expressed ICAM-1 and CD31.	Nitroblue Tetrazolium	0-21	platelet and endothelial cell adhesion molecule 1	Homo sapiens	113-117
8578193-9	1995	E-selectin positivity in association with nitroblue tetrazolium reduction was mainly seen in the large mucosal vessels, but capillaries showing nitroblue tetrazolium reduction were rarely positive for E-selectin.	Nitroblue Tetrazolium	42-63	selectin E	Homo sapiens	0-10
8569737-6	1995	And finally, the data is presented that acetylcholine-induced elevations of intracellular levels of cyclic GMP can be attenuated by muscarinic antagonist, atropine and superoxide anion scavenger, nitroblue tetrazolium.	Nitroblue Tetrazolium	196-217	5'-nucleotidase, cytosolic II	Homo sapiens	107-110
7621441-3	1995	Induction of differentiation observed are in the order SBP > SBA > SBF, as assessed by morphology, NBT-reducing activity and surface marker antigens of the treated cells.	Nitroblue Tetrazolium	105-108	selenium binding protein 1	Homo sapiens	55-58
7549963-2	1995	The assay is based on the SOD-mediated inhibition in the rate of nitroblue tetrazolium reduction to the blue formazan at alkaline pH.	Nitroblue Tetrazolium	65-86	superoxide dismutase 1	Homo sapiens	26-29
7805791-3	1994	Hybrid chains formed by probe and calcitonin mRNA were visualized by anti-digoxigenin-alkaline phosphatase conjugate, nitroblue tetrazolium (NBT) and X-phosphate (Boehringer Mannheim).	Nitroblue Tetrazolium	118-139	calcitonin-related polypeptide alpha	Rattus norvegicus	34-44
7890662-4	1995	The initial decline in FPGS activity preceded any effect of Me2SO on rate of growth and the increase in appearance of nitro blue tetrazolium-positive cells, a marker of cellular maturation, and the decrease after 5 days of exposure to Me2SO was solely accounted for by a 7-fold decrease in value for Vmax.	Nitroblue Tetrazolium	118-140	folylpolyglutamate synthase	Homo sapiens	23-27
7528568-5	1995	The cells expressing a high level of D-factor receptor were induced to differentiate by D-factor; about 60% of the cells exhibited the ability to reduce nitroblue tetrazolium and expression of the differentiation antigen Mac-1 (CD11b) on the cell surface increased.	Nitroblue Tetrazolium	153-174	leukemia inhibitory factor	Mus musculus	37-45
7591362-4	1995	GM-CSF and M-CSF demonstrated equipotency in the induction of monocyte phagocytosis of heat-killed baker"s yeast and in the regulation of the hexose-monophosphate shunt (NBT reduction).	Nitroblue Tetrazolium	170-173	colony stimulating factor 2	Homo sapiens	0-6
7591362-4	1995	GM-CSF and M-CSF demonstrated equipotency in the induction of monocyte phagocytosis of heat-killed baker"s yeast and in the regulation of the hexose-monophosphate shunt (NBT reduction).	Nitroblue Tetrazolium	170-173	colony stimulating factor 1	Homo sapiens	1-6
8987500-2	1995	STL-1 markedly increased differention-associated characteristics in macrophage, such as nitroblue tetrazolium reducing ability, appearance of Fc receptor, phagocytic activities in U937.	Nitroblue Tetrazolium	88-109	collagen type II alpha 1 chain	Homo sapiens	0-5
7751736-7	1995	Furthermore, hM-CSF enhanced the activity of RES organ, phagocytosis by macrophages and NBT reduction by macrophages, significantly.	Nitroblue Tetrazolium	88-91	colony stimulating factor 1	Homo sapiens	13-19
8050170-2	1994	In the present study we examined the ability to generate reactive oxygen species (ROS) in isolated monocytes from these patients by two different methods: superoxide dismutase (SOD) inhibitable cytochrome c reduction by O2- and nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	251-254	superoxide dismutase 1	Homo sapiens	155-175
7806621-12	1994	Within the same period, relatively small number of TNF-alpha treated THP-1 cells had differentiated to macrophages as detected by the reduction of nitro blue tetrazolium (NBT) (35% of total cells) and by the counting of adherent cells (35% of total cells).	Nitroblue Tetrazolium	147-169	tumor necrosis factor	Homo sapiens	51-60
7806621-12	1994	Within the same period, relatively small number of TNF-alpha treated THP-1 cells had differentiated to macrophages as detected by the reduction of nitro blue tetrazolium (NBT) (35% of total cells) and by the counting of adherent cells (35% of total cells).	Nitroblue Tetrazolium	147-169	GLI family zinc finger 2	Homo sapiens	69-74
7806621-12	1994	Within the same period, relatively small number of TNF-alpha treated THP-1 cells had differentiated to macrophages as detected by the reduction of nitro blue tetrazolium (NBT) (35% of total cells) and by the counting of adherent cells (35% of total cells).	Nitroblue Tetrazolium	171-174	tumor necrosis factor	Homo sapiens	51-60
7806621-12	1994	Within the same period, relatively small number of TNF-alpha treated THP-1 cells had differentiated to macrophages as detected by the reduction of nitro blue tetrazolium (NBT) (35% of total cells) and by the counting of adherent cells (35% of total cells).	Nitroblue Tetrazolium	171-174	GLI family zinc finger 2	Homo sapiens	69-74
8057087-3	1994	The detection of the rate constant of the reaction of superoxide ion with nitroblue tetrazolium (NBT) which is inhibited by superoxide dismutase (SOD) and its model compounds of the EGTB system has been performed by a modified illumination method.	Nitroblue Tetrazolium	74-95	superoxide dismutase 1	Homo sapiens	124-144
8057087-3	1994	The detection of the rate constant of the reaction of superoxide ion with nitroblue tetrazolium (NBT) which is inhibited by superoxide dismutase (SOD) and its model compounds of the EGTB system has been performed by a modified illumination method.	Nitroblue Tetrazolium	74-95	superoxide dismutase 1	Homo sapiens	146-149
8057087-3	1994	The detection of the rate constant of the reaction of superoxide ion with nitroblue tetrazolium (NBT) which is inhibited by superoxide dismutase (SOD) and its model compounds of the EGTB system has been performed by a modified illumination method.	Nitroblue Tetrazolium	97-100	superoxide dismutase 1	Homo sapiens	124-144
8057087-3	1994	The detection of the rate constant of the reaction of superoxide ion with nitroblue tetrazolium (NBT) which is inhibited by superoxide dismutase (SOD) and its model compounds of the EGTB system has been performed by a modified illumination method.	Nitroblue Tetrazolium	97-100	superoxide dismutase 1	Homo sapiens	146-149
8050170-2	1994	In the present study we examined the ability to generate reactive oxygen species (ROS) in isolated monocytes from these patients by two different methods: superoxide dismutase (SOD) inhibitable cytochrome c reduction by O2- and nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	251-254	superoxide dismutase 1	Homo sapiens	177-180
7520101-5	1994	Interestingly, G-CSF or GM-CSF potentiated the capability of ATRA-induced cells to reduce nitroblue tetrazolium (NBT), while G-CSF or GM-CSF alone induced no NBT reduction.	Nitroblue Tetrazolium	90-111	colony stimulating factor 3	Homo sapiens	15-20
7526942-7	1994	The co-purification and the competitive inhibition of NOS by the NADPHd substrate, nitro blue tetrazolium (NBT), are proof that in insects the enzyme responsible for fixation-insensitive NADPHd activity is nitric oxide synthase.	Nitroblue Tetrazolium	83-105	Nitric oxide synthase	Drosophila melanogaster	206-227
7526942-7	1994	The co-purification and the competitive inhibition of NOS by the NADPHd substrate, nitro blue tetrazolium (NBT), are proof that in insects the enzyme responsible for fixation-insensitive NADPHd activity is nitric oxide synthase.	Nitroblue Tetrazolium	107-110	Nitric oxide synthase	Drosophila melanogaster	206-227
7520101-5	1994	Interestingly, G-CSF or GM-CSF potentiated the capability of ATRA-induced cells to reduce nitroblue tetrazolium (NBT), while G-CSF or GM-CSF alone induced no NBT reduction.	Nitroblue Tetrazolium	90-111	colony stimulating factor 2	Homo sapiens	24-30
7520101-5	1994	Interestingly, G-CSF or GM-CSF potentiated the capability of ATRA-induced cells to reduce nitroblue tetrazolium (NBT), while G-CSF or GM-CSF alone induced no NBT reduction.	Nitroblue Tetrazolium	113-116	colony stimulating factor 3	Homo sapiens	15-20
7520101-5	1994	Interestingly, G-CSF or GM-CSF potentiated the capability of ATRA-induced cells to reduce nitroblue tetrazolium (NBT), while G-CSF or GM-CSF alone induced no NBT reduction.	Nitroblue Tetrazolium	113-116	colony stimulating factor 2	Homo sapiens	24-30
7954742-6	1994	The activity of platelet SOD was determined by measuring reductivity of nitroblue tetrazolium.	Nitroblue Tetrazolium	72-93	superoxide dismutase 1	Homo sapiens	25-28
7947389-5	1994	When these clones were examined immediately after their establishment, expression of c-jun was accompanied by the appearance of a mature phenotype in many clones, as measured by the reduction of nitroblue tetrazolium and by the expression of Mac-1 (CD11b), a cell surface marker on differentiated cells.	Nitroblue Tetrazolium	195-216	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	85-90
8182064-11	1994	TNF induced NBT-reducing activity in a dose-dependent manner, whereas LT was essentially inactive.	Nitroblue Tetrazolium	12-15	tumor necrosis factor	Homo sapiens	0-3
8182064-13	1994	By using receptor-blocking antibodies we found that both p60 and p80 forms of TNF receptors were functional for NBT-reducing activity, but TNF-dependent NF-kappa B activation required only the p60 receptor.	Nitroblue Tetrazolium	112-115	interferon induced protein with tetratricopeptide repeats 3	Homo sapiens	57-60
8182064-13	1994	By using receptor-blocking antibodies we found that both p60 and p80 forms of TNF receptors were functional for NBT-reducing activity, but TNF-dependent NF-kappa B activation required only the p60 receptor.	Nitroblue Tetrazolium	112-115	coilin	Homo sapiens	65-68
8182064-13	1994	By using receptor-blocking antibodies we found that both p60 and p80 forms of TNF receptors were functional for NBT-reducing activity, but TNF-dependent NF-kappa B activation required only the p60 receptor.	Nitroblue Tetrazolium	112-115	tumor necrosis factor	Homo sapiens	78-81
8161788-5	1994	Morphological analysis, flow-cytometric determination of granulocytic or monocytic surface markers, and ability to reduce nitroblue tetrazolium (NBT) demonstrated that expression of exogenous wild-type p53 gene in HL-60 cells induces differentiation through the granulocytic pathway.	Nitroblue Tetrazolium	122-143	tumor protein p53	Homo sapiens	202-205
8161788-5	1994	Morphological analysis, flow-cytometric determination of granulocytic or monocytic surface markers, and ability to reduce nitroblue tetrazolium (NBT) demonstrated that expression of exogenous wild-type p53 gene in HL-60 cells induces differentiation through the granulocytic pathway.	Nitroblue Tetrazolium	145-148	tumor protein p53	Homo sapiens	202-205
8141790-1	1994	The effect of tumour necrosis factor alpha (TNF alpha) on superoxide generation in human neutrophils was investigated using the Nitro Blue Tetrazolium reduction assay.	Nitroblue Tetrazolium	128-150	tumor necrosis factor	Homo sapiens	44-53
7689128-1	1993	Recombinant human granulocyte colony-stimulating factor (rhG-CSF) not only enhanced the growth of HL-60 cells, but also significantly increased NBT-reducing ability and alkaline phosphatase (ALP) activity of the cells, which were enhanced by the treatment with retinoic acid (RA).	Nitroblue Tetrazolium	144-147	colony stimulating factor 3	Homo sapiens	18-55
7931813-6	1994	The mean values of fructosamine measured by the NBT reaction in the glycosylated-laminin and fibronectin were increased dose dependently.	Nitroblue Tetrazolium	48-51	fibronectin 1	Rattus norvegicus	93-104
8250238-5	1993	Gb3 was visualized with NBT and BCIP and quantitated by densitometry.	Nitroblue Tetrazolium	24-27	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	0-3
8132222-4	1994	However, combinations of IL-4 and TNF-alpha acted in synergy to inhibit cell proliferation and induce monocytic differentiation of JCS cells, as shown by increased expression of the macrophage differentiation antigens (F4/80, Mac-1), stimulation of phagocytic activity, induction of non-specific esterase and NBT-reducing activities, increased plastic adherence and morphological criteria.	Nitroblue Tetrazolium	309-312	interleukin 4	Mus musculus	25-29
8132222-4	1994	However, combinations of IL-4 and TNF-alpha acted in synergy to inhibit cell proliferation and induce monocytic differentiation of JCS cells, as shown by increased expression of the macrophage differentiation antigens (F4/80, Mac-1), stimulation of phagocytic activity, induction of non-specific esterase and NBT-reducing activities, increased plastic adherence and morphological criteria.	Nitroblue Tetrazolium	309-312	tumor necrosis factor	Mus musculus	34-43
8262554-1	1993	Involvement of protein kinase C. The peptides neuropeptide Y (NPY) and peptide YY (PYY) at concentrations from 10(-12) M to 10(-8) M have been shown in this study to stimulate significantly, in vitro, several functions of resting peritoneal macrophages from BALB/c mice: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and foreign cells (Candida albicans), and production of superoxide anion measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	435-456	neuropeptide Y	Mus musculus	46-60
8262554-1	1993	Involvement of protein kinase C. The peptides neuropeptide Y (NPY) and peptide YY (PYY) at concentrations from 10(-12) M to 10(-8) M have been shown in this study to stimulate significantly, in vitro, several functions of resting peritoneal macrophages from BALB/c mice: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and foreign cells (Candida albicans), and production of superoxide anion measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	435-456	neuropeptide Y	Mus musculus	62-65
8262554-1	1993	Involvement of protein kinase C. The peptides neuropeptide Y (NPY) and peptide YY (PYY) at concentrations from 10(-12) M to 10(-8) M have been shown in this study to stimulate significantly, in vitro, several functions of resting peritoneal macrophages from BALB/c mice: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and foreign cells (Candida albicans), and production of superoxide anion measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	435-456	peptide YY	Mus musculus	71-81
8262554-1	1993	Involvement of protein kinase C. The peptides neuropeptide Y (NPY) and peptide YY (PYY) at concentrations from 10(-12) M to 10(-8) M have been shown in this study to stimulate significantly, in vitro, several functions of resting peritoneal macrophages from BALB/c mice: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and foreign cells (Candida albicans), and production of superoxide anion measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	435-456	peptide YY	Mus musculus	83-86
8394678-3	1993	Utr-1, which recognizes the 75 kDa receptor, blocked 125I-TNF binding by about 80% and inhibited by about 80% the TNF-induced NBT reducing activity.	Nitroblue Tetrazolium	126-129	tumor necrosis factor	Homo sapiens	114-117
8394678-4	1993	Htr-5 recognizes the 55 kDa receptor, blocked 125I-TNF binding by about 20% and inhibited by about 60% the TNF-induced NBT reducing activity.	Nitroblue Tetrazolium	119-122	tumor necrosis factor	Homo sapiens	107-110
8489236-6	1993	NADH was not an effective electron donor for cytochrome c reduction and NADPH-dependent reduction of nitroblue tetrazolium was negligibly small.	Nitroblue Tetrazolium	101-122	2,4-dienoyl-CoA reductase 1	Homo sapiens	72-77
8236374-6	1993	In marked contrast, in SOC, addition of IL-7 resulted in the growth of gamma delta T-cells not only in FT but also in NBT, despite the fact that the SOC of NBT without exogenous cytokine exclusively promoted the growth of alpha beta T-cells.	Nitroblue Tetrazolium	118-121	interleukin 7	Mus musculus	40-44
8236374-6	1993	In marked contrast, in SOC, addition of IL-7 resulted in the growth of gamma delta T-cells not only in FT but also in NBT, despite the fact that the SOC of NBT without exogenous cytokine exclusively promoted the growth of alpha beta T-cells.	Nitroblue Tetrazolium	156-159	interleukin 7	Mus musculus	40-44
8471626-3	1993	Nitroblue tetrazolium (NBT)-reducing activity, a typical marker of myelomonocytic differentiation, of U937 cells was induced by genistein and GM-CSF enhanced this activity.	Nitroblue Tetrazolium	0-21	colony stimulating factor 2	Homo sapiens	142-148
8471626-3	1993	Nitroblue tetrazolium (NBT)-reducing activity, a typical marker of myelomonocytic differentiation, of U937 cells was induced by genistein and GM-CSF enhanced this activity.	Nitroblue Tetrazolium	23-26	colony stimulating factor 2	Homo sapiens	142-148
8471626-4	1993	GM-CSF also induced the NBT-reducing activity of the cells in combination with 2,5-dihydroxycinnamic acid methyl ester, psi-tectorigenin and staurosporine, although each of them did not induce the activity.	Nitroblue Tetrazolium	24-27	colony stimulating factor 2	Homo sapiens	0-6
7680656-3	1993	A high level of expression of the G-CSFR did not promote or suppress cellular proliferation or initiate differentiation; however, exposure of transfected cells to G-CSF in suspension culture caused a large percentage of the population to enter a differentiation pathway, as determined by two markers of the mature state, the ability of cells to reduce nitroblue tetrazolium (NBT) and to express the differentiation antigen Mac-1 (CD11b) on the cell surface.	Nitroblue Tetrazolium	352-373	colony stimulating factor 3 receptor	Homo sapiens	34-40
7680656-3	1993	A high level of expression of the G-CSFR did not promote or suppress cellular proliferation or initiate differentiation; however, exposure of transfected cells to G-CSF in suspension culture caused a large percentage of the population to enter a differentiation pathway, as determined by two markers of the mature state, the ability of cells to reduce nitroblue tetrazolium (NBT) and to express the differentiation antigen Mac-1 (CD11b) on the cell surface.	Nitroblue Tetrazolium	352-373	colony stimulating factor 3	Homo sapiens	34-39
7680656-3	1993	A high level of expression of the G-CSFR did not promote or suppress cellular proliferation or initiate differentiation; however, exposure of transfected cells to G-CSF in suspension culture caused a large percentage of the population to enter a differentiation pathway, as determined by two markers of the mature state, the ability of cells to reduce nitroblue tetrazolium (NBT) and to express the differentiation antigen Mac-1 (CD11b) on the cell surface.	Nitroblue Tetrazolium	375-378	colony stimulating factor 3 receptor	Homo sapiens	34-40
7680656-3	1993	A high level of expression of the G-CSFR did not promote or suppress cellular proliferation or initiate differentiation; however, exposure of transfected cells to G-CSF in suspension culture caused a large percentage of the population to enter a differentiation pathway, as determined by two markers of the mature state, the ability of cells to reduce nitroblue tetrazolium (NBT) and to express the differentiation antigen Mac-1 (CD11b) on the cell surface.	Nitroblue Tetrazolium	375-378	colony stimulating factor 3	Homo sapiens	34-39
7680656-4	1993	Thus, upon treatment with 10 ng/ml of G-CSF, 60% or more of transfected cells exhibited NBT positivity; whereas, in contrast, nontransfected cells exhibited only 6% NBT positivity in response to G-CSF.	Nitroblue Tetrazolium	88-91	colony stimulating factor 3 (granulocyte)	Mus musculus	38-43
7680656-4	1993	Thus, upon treatment with 10 ng/ml of G-CSF, 60% or more of transfected cells exhibited NBT positivity; whereas, in contrast, nontransfected cells exhibited only 6% NBT positivity in response to G-CSF.	Nitroblue Tetrazolium	165-168	colony stimulating factor 3 (granulocyte)	Mus musculus	38-43
18475503-1	1993	Phorbol-12-myristate-13-acetate (PMA), calcium ionophore A23187 and platelet activating factor (PAF) stimulated the generation of oxygen free radicals (nitro-blue tetrazolium reduction) in Ehrlich ascites tumour (EAT) cells.	Nitroblue Tetrazolium	152-174	patchy fur	Mus musculus	96-99
25990524-6	1993	In 12 cases of clinically diagnosed infarction, H-FABP depletion could be demonstrated in areas that showed normal NBT staining.	Nitroblue Tetrazolium	115-118	fatty acid binding protein 3	Homo sapiens	48-54
8380808-1	1993	The neuropeptides neurotensin and neuromedin N (from 10(-12) M to 10(-9) M) have been shown in this study to stimulate significantly in vitro several steps of the phagocytic process: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and production of superoxide anion measured by nitroblue tetrazolium reduction in resting peritoneal macrophages from BALB/c mice.	Nitroblue Tetrazolium	309-330	neurotensin	Mus musculus	18-29
8380808-1	1993	The neuropeptides neurotensin and neuromedin N (from 10(-12) M to 10(-9) M) have been shown in this study to stimulate significantly in vitro several steps of the phagocytic process: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and production of superoxide anion measured by nitroblue tetrazolium reduction in resting peritoneal macrophages from BALB/c mice.	Nitroblue Tetrazolium	309-330	neurotensin	Mus musculus	34-46
8453769-0	1993	A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	94-115	superoxide dismutase 1	Homo sapiens	29-49
8453769-0	1993	A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	94-115	superoxide dismutase 1	Homo sapiens	51-54
8453769-0	1993	A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	117-120	superoxide dismutase 1	Homo sapiens	29-49
8453769-0	1993	A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction.	Nitroblue Tetrazolium	117-120	superoxide dismutase 1	Homo sapiens	51-54
8462021-4	1993	The combined treatment of human myeloid leukemia cells by ara-C and LIF is associated with down-regulation of c-myc gene expression, transcriptional activation of jun/fos gene expression, and features of functional differentiation (e.g., the capability to reduce nitroblue tetrazolium, to express lysozyme, or to display differentiation-related surface receptors including C3bi and the c-fms protein).	Nitroblue Tetrazolium	263-284	LIF interleukin 6 family cytokine	Homo sapiens	68-71
1482652-3	1992	PEG-GM-CSF was unexpectedly more active than GM-CSF in its ability to prime neutrophils to respond to the synthetic peptide n-formyl-methionyl-leucyl-phenylalanine (FMLP) with an oxidative burst (assessed both by nitroblue tetrazolium reduction and ferricytochrome c reduction).	Nitroblue Tetrazolium	213-234	colony stimulating factor 2	Homo sapiens	4-10
1482652-3	1992	PEG-GM-CSF was unexpectedly more active than GM-CSF in its ability to prime neutrophils to respond to the synthetic peptide n-formyl-methionyl-leucyl-phenylalanine (FMLP) with an oxidative burst (assessed both by nitroblue tetrazolium reduction and ferricytochrome c reduction).	Nitroblue Tetrazolium	213-234	formyl peptide receptor 1	Homo sapiens	165-169
1419892-7	1992	The results demonstrate that the 3 beta-HSD activity can be measured in a rapid and reliable way by measuring the reduction of nitroblue tetrazolium.	Nitroblue Tetrazolium	127-148	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1	Rattus norvegicus	33-43
1419892-2	1992	A rapid and simple method for measuring the 3 beta-HSD activity has been developed, in which the NADH, generated by 3 beta-HSD, reduced nitroblue tetrazolium to a product with absorption maximum at 560 nm.	Nitroblue Tetrazolium	136-157	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1	Rattus norvegicus	44-54
1326533-6	1992	However, the system showed high O2(-)-generating activity of 31.8 mol/s/mol of cytochrome b558 (52.5% of the original O2(-)-generating activity of the solubilized membranes) in the presence of a nitro blue tetrazolium (NBT) reductase fraction that was separated from the cytochrome b fraction by heparin-Sepharose chromatography.	Nitroblue Tetrazolium	195-217	cytochrome b	Oryctolagus cuniculus	79-91
1419892-2	1992	A rapid and simple method for measuring the 3 beta-HSD activity has been developed, in which the NADH, generated by 3 beta-HSD, reduced nitroblue tetrazolium to a product with absorption maximum at 560 nm.	Nitroblue Tetrazolium	136-157	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1	Rattus norvegicus	116-126
1306413-1	1992	Authors studied experimentally PAM NBT reduction function in patients with lung cancer.	Nitroblue Tetrazolium	35-38	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	31-34
1306413-2	1992	Results indicate that PMN and lymphocyte counts in the lung cancer group are significantly lower than that in the control group, and NBT reduction of PAM is significantly decreased.	Nitroblue Tetrazolium	133-136	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	150-153
1326533-6	1992	However, the system showed high O2(-)-generating activity of 31.8 mol/s/mol of cytochrome b558 (52.5% of the original O2(-)-generating activity of the solubilized membranes) in the presence of a nitro blue tetrazolium (NBT) reductase fraction that was separated from the cytochrome b fraction by heparin-Sepharose chromatography.	Nitroblue Tetrazolium	219-222	cytochrome b	Oryctolagus cuniculus	79-91
1323343-2	1992	Continuous exposure of HL-60 cells to GM-CSF induced the cell differentiation that was evaluated by the nitroblue tetrazolium (NBT) reducing activity.	Nitroblue Tetrazolium	104-125	colony stimulating factor 2	Homo sapiens	38-44
1323343-2	1992	Continuous exposure of HL-60 cells to GM-CSF induced the cell differentiation that was evaluated by the nitroblue tetrazolium (NBT) reducing activity.	Nitroblue Tetrazolium	127-130	colony stimulating factor 2	Homo sapiens	38-44
1312372-7	1992	In some patients, rIFN-gamma therapy was associated with the appearance of a small subset of circulating monocytes (1% to 20%) that were NBT-positive.	Nitroblue Tetrazolium	137-140	interferon gamma	Rattus norvegicus	18-28
1508958-5	1992	PMA-induced differentiation and nitroblue tetrazolium reduction by PMA-treated cells was only partially inhibited (about 20-30%) by indomethacin and nordihydroguiaretic acid (cyclooxygenase and lipoxygenase inhibitors respectively), but not by superoxide dismutase, catalase or mannitol.	Nitroblue Tetrazolium	32-53	catalase	Homo sapiens	266-274
1359172-3	1992	IR-CRH was detectable in 21 neuroendocrine tumors (10 PET, four NBT, three CA, two PHEO and two SCLC) at levels of 10-2,700 ng/g wet weight (9.6%).	Nitroblue Tetrazolium	64-67	corticotropin releasing hormone	Homo sapiens	3-6
1378916-3	1992	Combinations of G-CSF and RA produced a supra-additive increase in the percentage of WEHI-3B D+ cells reducing nitro blue tetrazolium and expressing Mac-1 (CD11b) antigen on the cell surface, two markers of the mature state.	Nitroblue Tetrazolium	111-133	colony stimulating factor 3 (granulocyte)	Mus musculus	16-21
1352926-3	1992	The chemiluminescence of patient neutrophils activated by C3b-opsonized particles was, consequently, significantly decreased compared with that of control neutrophils, while the respiratory burst assayed by phorbolmyristate acid (PMA) stimulated nitroblue tetrazolium (NBT)-reduction was normal in the patient group.	Nitroblue Tetrazolium	246-267	endogenous retrovirus group K member 3	Homo sapiens	58-61
1352926-3	1992	The chemiluminescence of patient neutrophils activated by C3b-opsonized particles was, consequently, significantly decreased compared with that of control neutrophils, while the respiratory burst assayed by phorbolmyristate acid (PMA) stimulated nitroblue tetrazolium (NBT)-reduction was normal in the patient group.	Nitroblue Tetrazolium	269-272	endogenous retrovirus group K member 3	Homo sapiens	58-61
2064356-7	1991	PSK stimulated the NBT-reducing activity of mouse peritoneal macrophages and the iodination (incorporation of radioactive iodine into an acid-insoluble fraction) of human peripheral blood polymorphonuclear cells (PMN).	Nitroblue Tetrazolium	19-22	TAO kinase 2	Mus musculus	0-3
1311213-10	1992	Rather, three of 10 evaluable nBTs had bcl-2 rearrangements.	Nitroblue Tetrazolium	30-34	BCL2 apoptosis regulator	Homo sapiens	39-44
1723851-5	1991	The NADH formed in the oxidative deamination of methionine reacts with PMS and NBT to form a blue band on the surface of the gel coincident with glutamine transaminase K activity.	Nitroblue Tetrazolium	79-82	kynurenine aminotransferase 1	Rattus norvegicus	145-169
1723851-6	1991	Cysteine S-conjugate beta-lyase activity is detected in the gel by incubating the gel with a reaction mixture containing alpha KMB (to ensure maintenance of the enzyme in the pyridoxal 5"-phosphate form), S-(1,2-dichlorovinyl)-L-cysteine (DCVC), PMS, and NBT.	Nitroblue Tetrazolium	255-258	kynurenine aminotransferase 1	Rattus norvegicus	0-31
1768050-1	1991	When mouse resident peritoneal macrophages were cultured with PSK (Krestin), a protein-bound polysaccharide extracted from Coriolus versicolor, they became enlarged and elongated and expressed higher NBT-reducing activity.	Nitroblue Tetrazolium	200-203	TAO kinase 2	Mus musculus	62-65
2043477-7	1991	Priming of PMN by GH was confirmed by direct demonstration of a stimulatory effect on reduction of nitroblue tetrazolium.	Nitroblue Tetrazolium	99-120	growth hormone 1	Homo sapiens	18-20
1370331-5	1992	The binding of 125I-labeled KW-2228, a muteins of G-CSF, to KU-1 and NBT-2 was inhibited by unlabeled KW-2228 in a dose-dependent manner.	Nitroblue Tetrazolium	69-72	colony stimulating factor 3	Homo sapiens	50-55
1954981-2	1991	This study documents that this discrepancy of the CL response to fMLP and PMA remained over a wide range of stimuli concentrations, was not due to iron-deficient PV cells and was also observed with the nitroblue tetrazolium assay.	Nitroblue Tetrazolium	202-223	formyl peptide receptor 1	Homo sapiens	65-69
1649124-1	1991	Bombesin, as well as the two mammalian bombesin-like peptides gastrin-releasing peptide and neuromedin C, have been shown in this study to stimulate in vitro all steps of the phagocytic process in murine peritoneal macrophages: adherence to substrate, chemotaxis, ingestion of cells (Candida albicans) and inert particles (latex beads), and production of superoxide anion as measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	387-408	gastrin releasing peptide	Homo sapiens	0-8
1649124-1	1991	Bombesin, as well as the two mammalian bombesin-like peptides gastrin-releasing peptide and neuromedin C, have been shown in this study to stimulate in vitro all steps of the phagocytic process in murine peritoneal macrophages: adherence to substrate, chemotaxis, ingestion of cells (Candida albicans) and inert particles (latex beads), and production of superoxide anion as measured by nitroblue tetrazolium reduction.	Nitroblue Tetrazolium	387-408	gastrin releasing peptide	Homo sapiens	92-104
1995312-3	1991	After treatment with DMSO, GM-CSF delayed expression of some HL60 differentiation programs (CD11b expression), but not others (nitro blue tetrazolium dye reduction), and delayed the exit of cells from the cell cycle.	Nitroblue Tetrazolium	127-149	colony stimulating factor 2	Homo sapiens	27-33
1856112-5	1991	Both enzymes react to phenazine methosulfate (PMS) which transfers reduction equivalents to the electron acceptor nitroblue tetrazolium chloride (NBT), thus causing a coreaction of GPDH in the demonstration of NAD-GPDH.	Nitroblue Tetrazolium	114-144	glycerol-3-phosphate dehydrogenase 1	Rattus norvegicus	181-185
1856112-5	1991	Both enzymes react to phenazine methosulfate (PMS) which transfers reduction equivalents to the electron acceptor nitroblue tetrazolium chloride (NBT), thus causing a coreaction of GPDH in the demonstration of NAD-GPDH.	Nitroblue Tetrazolium	114-144	glycerol-3-phosphate dehydrogenase 1	Rattus norvegicus	214-218
1856112-5	1991	Both enzymes react to phenazine methosulfate (PMS) which transfers reduction equivalents to the electron acceptor nitroblue tetrazolium chloride (NBT), thus causing a coreaction of GPDH in the demonstration of NAD-GPDH.	Nitroblue Tetrazolium	146-149	glycerol-3-phosphate dehydrogenase 1	Rattus norvegicus	181-185
1856112-5	1991	Both enzymes react to phenazine methosulfate (PMS) which transfers reduction equivalents to the electron acceptor nitroblue tetrazolium chloride (NBT), thus causing a coreaction of GPDH in the demonstration of NAD-GPDH.	Nitroblue Tetrazolium	146-149	glycerol-3-phosphate dehydrogenase 1	Rattus norvegicus	214-218
2344669-7	1990	As expected, NBT levels were significantly lower (299 micrograms/g) in tissue that was continuously suffused with superoxide dismutase (SOD) plus catalase (CAT) before occlusion and during reperfusion.	Nitroblue Tetrazolium	13-16	catalase	Homo sapiens	146-154
2176110-7	1990	By contrast, colonies derived 7 days after a single INF-gamma injection were able to generate superoxide as shown by increased NBT reduction.	Nitroblue Tetrazolium	127-130	interferon gamma	Homo sapiens	52-61
1705636-5	1991	G-CSF induced TPA- and FMLP-stimulated NBT reduction in the presence of 100 nM RA, but GM-CSF induced only TPA-stimulated NBT reduction.	Nitroblue Tetrazolium	39-42	colony stimulating factor 3	Homo sapiens	0-5
1705636-5	1991	G-CSF induced TPA- and FMLP-stimulated NBT reduction in the presence of 100 nM RA, but GM-CSF induced only TPA-stimulated NBT reduction.	Nitroblue Tetrazolium	39-42	formyl peptide receptor 1	Homo sapiens	23-27
1705636-5	1991	G-CSF induced TPA- and FMLP-stimulated NBT reduction in the presence of 100 nM RA, but GM-CSF induced only TPA-stimulated NBT reduction.	Nitroblue Tetrazolium	122-125	colony stimulating factor 2	Homo sapiens	87-93
2172251-6	1990	When exposed to NBT and NADPH this component of the oxidoreductase generates superoxide independent of cytochrome b.	Nitroblue Tetrazolium	16-19	mitochondrially encoded cytochrome b	Homo sapiens	103-115
1703196-2	1990	IFN-gamma induced nitro blue tetrazolium (NBT) reducing activity of U-937 cells in a dose-dependent manner, while cAMP-inducing agents such as cholera toxin, prostaglandin E1, forskolin, and isoproterenol only marginally induced NBT reducing activity.	Nitroblue Tetrazolium	18-40	interferon gamma	Homo sapiens	0-9
1703196-2	1990	IFN-gamma induced nitro blue tetrazolium (NBT) reducing activity of U-937 cells in a dose-dependent manner, while cAMP-inducing agents such as cholera toxin, prostaglandin E1, forskolin, and isoproterenol only marginally induced NBT reducing activity.	Nitroblue Tetrazolium	42-45	interferon gamma	Homo sapiens	0-9
1703196-2	1990	IFN-gamma induced nitro blue tetrazolium (NBT) reducing activity of U-937 cells in a dose-dependent manner, while cAMP-inducing agents such as cholera toxin, prostaglandin E1, forskolin, and isoproterenol only marginally induced NBT reducing activity.	Nitroblue Tetrazolium	229-232	interferon gamma	Homo sapiens	0-9
1703196-3	1990	However, they all synergistically increased IFN-gamma induction of NBT reducing activity.	Nitroblue Tetrazolium	67-70	interferon gamma	Homo sapiens	44-53
2121089-2	1990	This improved assay incorporates detergent and uricase in a more concentrated nitroblue-tetrazolium reagent base compared to the earlier reagent (Johnson & Baker assay), including a new serum calibrator.	Nitroblue Tetrazolium	78-99	urate oxidase (pseudogene)	Homo sapiens	47-54
2319123-1	1990	An accurately validated method was developed for quantitative determination of succinate dehydrogenase (EC 1.3.99.1; SDH) activity in individual sympathetic neuron perikarya by microdensitometric measurement of an SDH-nitroblue tetrazolium-derived formazan final reaction product.	Nitroblue Tetrazolium	218-239	serine dehydratase	Rattus norvegicus	117-120
2166023-2	1990	IFN-gamma (100 units/ml) or cholera toxin (10(-9) M) alone only marginally induced various differentiation-associated characteristics such as NBT-reducing activity, phagocytic activity, a-naphthyl acetate esterase activity and surface markers.	Nitroblue Tetrazolium	142-145	interferon gamma	Homo sapiens	0-9
2319123-1	1990	An accurately validated method was developed for quantitative determination of succinate dehydrogenase (EC 1.3.99.1; SDH) activity in individual sympathetic neuron perikarya by microdensitometric measurement of an SDH-nitroblue tetrazolium-derived formazan final reaction product.	Nitroblue Tetrazolium	218-239	serine dehydratase	Rattus norvegicus	214-217
2368186-1	1990	A superoxide dismutase (SOD) activity in saliva and gastric juice has been revealed using the NBT reduction and adrenaline autooxidation assays.	Nitroblue Tetrazolium	94-97	superoxide dismutase 1	Homo sapiens	2-22
2368186-1	1990	A superoxide dismutase (SOD) activity in saliva and gastric juice has been revealed using the NBT reduction and adrenaline autooxidation assays.	Nitroblue Tetrazolium	94-97	superoxide dismutase 1	Homo sapiens	24-27
2181784-3	1990	A recent modification of the Nitroblue Tetrazolium (NBT) reagent, improved by addition of tensides and uricase, exhibits lower interference by lipaemia and urate.	Nitroblue Tetrazolium	29-50	urate oxidase (pseudogene)	Homo sapiens	103-110
2181784-3	1990	A recent modification of the Nitroblue Tetrazolium (NBT) reagent, improved by addition of tensides and uricase, exhibits lower interference by lipaemia and urate.	Nitroblue Tetrazolium	52-55	urate oxidase (pseudogene)	Homo sapiens	103-110
2105994-6	1990	However, nitroblue tetrazolium reducing activity was synergistically induced by combinations of TGF-beta 1 and TNF.	Nitroblue Tetrazolium	9-30	transforming growth factor beta 1	Homo sapiens	96-106
2105994-6	1990	However, nitroblue tetrazolium reducing activity was synergistically induced by combinations of TGF-beta 1 and TNF.	Nitroblue Tetrazolium	9-30	tumor necrosis factor	Homo sapiens	111-114
2105994-8	1990	Although IFN-gamma, IL-6, granulocyte CSF, and granulocyte-macrophage CSF-induced nitroblue tetrazolium reducing activity of U-937 cells, only IFN-gamma, and TNF induced it synergistically in combination with TGF-beta 1.	Nitroblue Tetrazolium	82-103	interferon gamma	Homo sapiens	9-18
2105994-8	1990	Although IFN-gamma, IL-6, granulocyte CSF, and granulocyte-macrophage CSF-induced nitroblue tetrazolium reducing activity of U-937 cells, only IFN-gamma, and TNF induced it synergistically in combination with TGF-beta 1.	Nitroblue Tetrazolium	82-103	interleukin 6	Homo sapiens	20-24
2105994-8	1990	Although IFN-gamma, IL-6, granulocyte CSF, and granulocyte-macrophage CSF-induced nitroblue tetrazolium reducing activity of U-937 cells, only IFN-gamma, and TNF induced it synergistically in combination with TGF-beta 1.	Nitroblue Tetrazolium	82-103	tumor necrosis factor	Homo sapiens	158-161
2105994-8	1990	Although IFN-gamma, IL-6, granulocyte CSF, and granulocyte-macrophage CSF-induced nitroblue tetrazolium reducing activity of U-937 cells, only IFN-gamma, and TNF induced it synergistically in combination with TGF-beta 1.	Nitroblue Tetrazolium	82-103	transforming growth factor beta 1	Homo sapiens	209-219
2337663-2	1990	The high level of the nitro-blue tetrazolium salt reduction in individual cells non-contacting with others is reached when using fibronectin or serum-opsonized zymosan but not phorbol myristate acetate or chemotactic formyl-peptide as activators.	Nitroblue Tetrazolium	22-49	fibronectin 1	Homo sapiens	129-140
1982480-3	1990	Both human CuZn-superoxide dismutase and host mouse CuZn-superoxide dismutase activities in cultured neurons were identified by native gel electrophoresis followed by nitroblue tetrazolium staining.	Nitroblue Tetrazolium	167-188	superoxide dismutase 1	Homo sapiens	11-36
1982480-3	1990	Both human CuZn-superoxide dismutase and host mouse CuZn-superoxide dismutase activities in cultured neurons were identified by native gel electrophoresis followed by nitroblue tetrazolium staining.	Nitroblue Tetrazolium	167-188	superoxide dismutase 1	Homo sapiens	52-77
34284182-7	2022	The potential benefits of NBT-reactive compounds on health were evaluated in the in vivo model of C. elegans where they activated the SKN-1/Nrf2 pathway, evidencing the ability of electrophilic compounds to induce a biological response.	Nitroblue Tetrazolium	26-29	BZIP domain-containing protein;Protein skinhead-1	Caenorhabditis elegans	134-139
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	181-201	superoxide dismutase 1	Homo sapiens	64-84
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	181-201	superoxide dismutase 1	Homo sapiens	86-89
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	181-201	superoxide dismutase 1	Homo sapiens	157-160
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	203-206	superoxide dismutase 1	Homo sapiens	64-84
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	203-206	superoxide dismutase 1	Homo sapiens	86-89
34770929-5	2021	Additionally, the antioxidant action was quantified through the superoxide dismutase (SOD)-like activity, using a protocol based on the inhibitory effect of SOD on the reduction of nitrobluetetrazolium (NBT) by the superoxide anion generated by the xanthine/xanthine oxidase system.	Nitroblue Tetrazolium	203-206	superoxide dismutase 1	Homo sapiens	157-160